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INTRODUCTION 
 
 Pregnancy is considered a unique, physiologically normal episode in a 
women’s life. While most pregnancies and births are uneventful, all pregnancies 
are at risk. Around 15% of all pregnant women develop a potentially life-
threatening complication which in turn require a major obstetrical intervention to 
survive.1 
 
 Labour is a naturally occurring phenomenon which usually starts on its 
own. Labour is defined as the spontaneous onset of regular painful uterine 
contractions associated with the progressive effacement and dilatation of the 
cervix and descent of the presenting part, with or without a ‘show’ or ruptured 
membrane.2 
 
 Preterm Labour (PTL) is defined by World Health Organization (WHO) as 
the onset of labour after the period of viability that is after 28 weeks of gestation 
and before 37 completed weeks or 259 days of pregnancy .It is estimated 15 
million preterm births occur worldwide. Pre-term birth is associated with 
significant perinatal morbidity and mortality rates. About 35% of preterm birth 
follows preterm pre-labour rupture of membrane.  The early detection of preterm 
labour or preterm rupture of membranes in traditional antenatal care is 
problematic because symptoms or signs may vary only a little from the normal 
physiological symptoms and signs of pregnancy.3 Hence detailed guidelines 
required to screen or manage pre-term labour. 
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 More than 1 in 10 of the world’s babies born in 2010 were born 
prematurely making an estimated 15 million preterm births (defined as before 37 
weeks of gestation), of which more than 1 million died as a result of their 
prematurity. Preterm birth is divided into several categories, based on weeks of 
gestational age: 
 
1) Extremely preterm (<28 weeks) 
2) Very preterm (28 to <32 weeks)   
3) Moderate to late preterm (32 to <37 weeks).  
4) Moderate preterm birth may be further split to focus on late preterm birth 
(34 - <37 completed weeks). 
 
 Preterm birth is a syndrome with a variety of causes which can be 
classified into two broad subtypes: 
 
1) Spontaneous preterm birth (spontaneous onset of  labour or following pre-
labour premature rupture of membranes (PPROM)) and 
2) Provider-initiated preterm birth (defined as induction of labour or elective 
caesarean birth before 37 completed weeks of gestation for maternal or 
fetal indications (both “urgent” and “discretionary”), or other non-medical 
reasons. Around 60% of preterm births in the world occur in Africa and 
South Asia, and it is truly a global problem. India had 3 519 100 preterm 
birth in 2010.4 
  
Review of Literature 
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REVIEW OF LITERATURE 
 
 WHO defines Preterm labour as “the commencement of regular uterine 
contractions, between viability and 37 weeks of gestation, along with cervical 
effacement and dilatation. 
 
Preterm delivery before 26 weeks or babies weighing less than 750 gm are 
at the current threshold of viability according to ACOG 2002, 2008 and suffer 
from many problems like medical, social. According to American Academy of 
Paediatrics current guidelines it is not necessary to resuscitate infants born prior to 
23 weeks or those weighing less than 400 gm. Infants born at 22, 23, 24, or 25 
weeks are considered to be under threshold due to immature organ systems. These 
infants are at higher risk for ischemic brain injuries as active brain development 
occurs during second and third trimester. 
 
 According to Tyson and associates (2008) factors improving the prognosis 
of preterm infants at the threshold of viability were singleton pregnancy, female 
gender, steroids given for foetal lung maturation, and higher gestational age. 
 
In 2008 Mc Intire and Leveno reported that idiopathic natural preterm 
labour or premature tear of membranes constituted 80% of late preterm births and 
the rest of 20% was constituted by complications like hypertension, placental 
abnormalities.  
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REASONS FOR PRETERM DELIVERY 
About 40-45% of preterm labour occurs spontaneously and 30% because of 
rupture of membranes (preterm) , and the rest 30-35% are induced preterm 
labours. One of the major reasons for preterm include multiple pregnancies. 
Etiology of preterm labour is multifactorial.  
 
Some of the factors attributing to preterm are:- 
 Delivery for maternal or fetal indications 
 Idiopathic preterm premature rupture of membranes 
 High order births 
 Uterine anomalies 
 Foetal anomalies 
 Genital tract infections 
 Placental causes 
 Foetal causes 
 Unexplained reasons 
 
Delivery for maternal or foetal indications: 
Indicated preterm delivery is done for various reasons. One third of 
preterm delivery is iatrogenic indicated for maternal or foetal reasons. These 
include: 
 
Maternal causes 
• Preeclampsia 
• Placenta previa 
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• Abruption 
• Chronic hypertension 
• Diabetes 
• Renal disease 
• Cardiac disease 
 
Foetal causes 
• Foetal distress 
• Severe foetal growth restriction due to utero placental insufficiency 
• Rh iso immunisation 
• Severe oligohydramnios 
• Congenital malformation. 
 
Idiopathic preterm premature rupture of membranes 
Preterm rupture of membranes may occur due to reduction of membrane 
strength or due to increased intrauterine pressure theoretically. The amniotic 
membranes is a connective tissue and any defect in synthesis, degradation or 
collagen quality can result in preterm rupture of membranes. 
 
High order births 
Multiple gestation constitutes about 12-15% of all preterm births. Multiple 
gestations cause over distention of uterus resulting in initiation of preterm labour, 
infection, preterm rupture of membranes..Early activation of CRH and the 
physiological pathway for parturition,and over distention mechanical force 
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leading to activation of protein kinase. Mitogen –activated protein kinases and 
increased expression of G proteins that induce myometrium contractility are the 
proposed mechanisms of preterm labour. 
 
Uterine Anomalies 
Congenital anatomical abnormalities of uterus and cervix are seen in 1-3% 
of preterm births. They occur due to mullerian ducts defect and septate and 
bicornuate uterus are clinically significant. The rate of preterm delivery in these 
patients range about 16-20%. Overdistention of uterus caused by multiple 
gestation, polyhydramnios also contribute to preterm labour. 
 
Cervical Abnormalities 
About 5 % of preterm births are due to anatomical or physiological 
abnormalities of cervix. These include women exposed to diethylstilboestrol 
during intrauterine period, who had conisations or cervical surgeries. 
 
Genital tract infections 
Infection is one of the most common cause of preterm labour and 
responsible for 20-40% of all preterm cases. The most accepted mechanism is 
ascending infection. This theory suggests an occurrence of break in the normal 
physiological barrier present between the vaginal flora and the products of 
conception. The vaginal bacteria ascend through the breech and colonise the 
decidua and chorion and then enters the amniotic fluid and the foetus. This is 
supported by the fact that organisms secluded from the amniotic fluid and the 
vagina are similar. The vaginal flora is separated by the cervix and the cervical 
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mucus plug. Cervical changes and changes in mucus plug contribute to ascending 
infection. Common organisms include Chlamydia, group B streptococcus, 
trichomonas, Gonococcus. Repeated pelvic examination during pregnancy and 
sexual intercourse are also implicated. 
 
According to Goldenberg and colleagues (2008b) these intrauterine 
infections trigger the innate immune system and activate preterm labour. These 
organisms initiate the release of inflammatory cytokines like tumour necrosis 
factor and interleukins which stimulates prostaglandins production which leads to 
uterine contractions there by leading to preterm labour. 
 
Intra uterine infections – Chorioamnionitis 
 Acute chorioamnionitis diagnosis is clinical and is diagnosed by the 
presence of fever and 2 of the following features maternal or foetal tachycardia, 
bad smell of amniotic fluid, maternal leucocytosis, uterine tenderness. Labour in 
these patients occur as a  protective mechanism. 
 
Subclinical chorioamnionitis is an infection of the conceptus without 
clinical signs or symptoms of the disease. This condition occurs in preterm labour 
with ruptured membranes or incompetent cervix. Patients with  subclinical 
chorioamnionitis present with uterine contractions. The diagnosis is by amniotic 
fluid analysis for Gram stain, white cell count, concentrations of interleukin 6, 
glucose, lactate dehydrogenase and cultures. The most common organisms 
isolated are Urea plasma urealyticum, Mycoplasma hominis,Fusobacterium 
species and Gardenella vaginalis. 
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The leukocyte count in amniotic fluid analysis WBC >12,000/mm3 or or 
left shift or bandemia (>9%) suggests chorioamnionitis. Concentration of glucose 
in amniotic fluid is also used as a method to diagnose chorioamnionitis. The best 
marker for chorioamnionitis is IL-6 concentration of greater than 7.9ng/ml in 
patients with ruptured membranes  and more than 11.39 ng/ml in patients with 
intact membranes. 
 
Extra uterine infections 
 Bacteria may acquire contact to the lower pole of the uterus though a 
normally functioning cervix, because of an increased number of virulent 
pathogens in the vagina, where they activate inflammatory mediators that leads to 
cervical ripening and shortening. Placental causes 
 Abnormal placentation 
 Anatomical  abnormalities 
 Placenta praevia 
 Abruption placenta 
 
Abnormal placentation 
Abnormal placentation has been implicated as one of the causes of preterm 
labour. Histological studies of placenta (Arias et al.,1993) in  preterm labour 
shows some defect in spiral arteries development, spiral artery thrombosis, and 
the placenta are small and have calcifications, infarctions and fibrosis  . Decrease 
in uteroplacental flow causes foetal growth retardation and hence account for low 
birth infants in preterm labour(Lackman et al., 2001). Studies have shown that 
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patients with Doppler abnormalities in early gestation have higher incidence of 
preterm labour. Abnormal morphology, implantation, and functions of placenta 
also result in preterm labour. 
 
Anatomical abnormalities 
Marginal insertion of cord, battledore placenta, circumvallate  placenta  are 
also associated  with preterm labour. 
 
Abruption placenta  
Placental Abruption is an abnormal premature separation of a normally 
implanted placenta. There are different kinds of abruption, based on the extent and 
region of separation. 
 
Abruption of the placenta may lead to preterm labour, through the 
thrombin release, which encourages myometrial contractions by protease-
activated receptors. With placental abruption, there is no time for pre-ripening of 
the uterine cervix to occur, hence the preterm labour with chorioamnionitis is 
mostly quick, whereas those with placental abruption, is less. (Phillip R.Bennet, 
2011). 
 
Placenta Previa 
 Placenta Previa can be defined as placenta inserted in wholly or partially in 
the lower uterine segment. This also causes preterm labour. 
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Foetal causes 
Birth defects were associated in preterm deliveries according to Dolan and 
colleagues (2007). 
 
EPIDEMIOLOGY 
RACE 
Preterm birth rates vary with different ethnicities and races. According to 
Goldenberg and colleagues in 2008 Black, African-American and Afro-Caribbean 
have a higher risk of preterm birth. Recurrent preterm birth is seen in black 
women according to Kistka and Colleagues, 2007. 
 
 Gene in 1996 reported that the rate of pre-term birth in African American 
women (2000) was not influenced by social and demographic factors. 
 
AGE: 
Preterm birth is associated with parity and maternal age. Young multiparae 
and older primiparae have higher risks of preterm delivery. According to Lumley 
Jm et al 1993 the incidence of preterm delivery is high in mothers less than 17 and 
more than 35 yrs. Very young maternal age can contribute to preterm labour 
(Amini et al, 1996). According to Hediger et al, (1997) adolescent girls less than 
16 years, have twice the risk of preterm labour considering with older women. At 
the other end, women aging 35 and over too higher preterm delivery risks (Astolfi 
and Zonna 2002) 
 
11 
 
WEIGHT 
Poor nutrition, pre pregnancy weight and weight gain during pregnancy 
play an important role in causing preterm labour. Hicklyand colleagues in 2005 
have reported that low maternal weight gain is often associated with preterm birth. 
 
STATURE 
Short statured women have tendencies to deliver small babies. According 
to Lao and Ho, 1997 indicated that preterm delivery and labour risks was more in 
teenage pregnancies, and the occurrence was conversely related with maternal 
height. This proposed that the characteristic risk of preterm delivery in teenagers 
was short stature, which in turn could have been a reflection of young physical 
development during pregnancy.  
 
SOCIOECONOMIC STATUS 
The reasons for socioeconomic differences in preterm births are not clear, 
and have not been much explored. A number of reasons like maternal nutrition, 
smoking, abuse, activities, work and prenatal care have been implicated with 
preterm births. Women from lower socio economic status tends to be less 
educated and would not have satisfactory general, prenatal and antenatal care 
(Goffinet F 2005) 
 
Low socioeconomic status on health appears to directly affect the incidence 
of preterm labour (Moutquin, 2003). Many studies show an correlation between 
preterm birth and numerous socioeconomic issues like societal class, education, 
marital status, earnings. Maternal nutrition before and during pregnancy have 
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contributed to the risk of preterm births, and this can be analysed by body mass 
index (WHO, 1995).  
 
ADDICTIONS 
Women who smoke and cocaine users are at increased risk of preterm 
labour (Bens 2004). The correlation between smoking and preterm birth was only 
existing among women with an increased intake of caffeine. Smoking more than 
20 cigarettes per day has resulted in the increased incidence of pre-term birth 
under 34 week’s gestation. Smoking initially associated with placental abruption, 
placenta praevia and pre mature rupture of membranes has now been linked with 
pre term delivery (Cnattingius 1998). Boer et al 1993, Volpe studied the increased 
incidence of pre-term birth in women addicted to opiods. Though, whether 
smoking alone effects the risk of preterm birth among heavy users of caffeine 
requires further investigation. 
 
Studies show women who abuse cocaine have high incidence of preterm 
labour, and it was partly attributed to the abruption caused by cocaine addiction. 
(Boer et al) 
 
Studies relating consumption of alcohol with the risk of pre-term labour are 
very few. 
 
Occupational hazards 
Those involved in manual work are more prone for preterm labour 
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PREDISPOSING FACTORS 
Stress: 
Preterm birth is associated with psychological factors such as depression, 
anxiety and chronic stress (Copper: 1996, Li 2008, Littleton 2007).Occupation 
which involve heavy physical work and psychological strain are associated with 
increased preterm births (Papiernik and Kaninski 1994).The utero placental flow 
decreases in prolonged standing and increases the frequency of placental infarcts 
causing intrauterine growth retardation. Preterm birth is increased in women who 
are subjected to physical abuse. Henribon et al 1995 reported that heavy vigorous 
exercise in the third trimester increased the risk of pre-term delivery while regular 
and moderate exercise were actually showing a reduced risk. 
 
Coitus 
Various theoretical mechanisms have been proposed for initiation of labour 
by sexual activity. These are nipple and genital stimulus may induce oxytocin 
release from the posterior pituitary, initiating uterine contractions.Prostaglandins 
that is released from mechanical stimulation of the cervix may be the reason of 
cervical ripening and prostaglandins in semen may also cause cervical ripening. 
Mills and co-workers found in singleton low-risk pregnancies sexual activity did 
not increase the frequency of preterm labour.  
 
The influence of sexual interaction on recurring preterm delivery in women 
with history of prior spontaneous preterm birth was studied by Yost and 
colleagues at less than 32 weeks’ gestation and concluded that sexual intercourse 
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had no effect on the occurrence of recurring preterm delivery. But the risk of 
recurrent preterm delivery increased with multiple sexual partners. 
 
Reproductive History  
a)Previous preterm birth     
The risk of preterm delivery increases with a history of previous preterm 
delivery. Spong, 2007 concluded that previous preterm delivery was a major risk 
factor for preterm labour. 
 
History of one previous preterm birth is associated with a recurrence risk of 
16-41 % (Williams 22”’ edition).Preterm delivery risks increases with the number 
of preterm birth and decreases with term deliveries. This risk is on an increasing 
trend whenever the number of prior preterm births increases (Hoffinan 1981). 
Women having a prior preterm delivery have threetimes the risk of recurrence 
compared to a woman who has got a previous term delivery. This risk increases to 
eight fold whenever there is a history of two preterm deliveries. Though preterm 
delivery is an important risk factor to recurrent preterm delivery, previous preterm 
birth contributes to only 10% of total preterm births(Bloom and associates 2001). 
Factors such as cervical length and inherent biological property of the cervix may 
contribute to the recurrence of preterm births. 
 
b)  Previous abortion 
Preterm deliveries increase in women who experienced one or more second 
trimester abortions. Earlier encouraged abortions were mainly linked with preterm 
delivery and the risk of preterm birth increased with the number of abortions. The 
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extent of association with previous induced abortion varied according to the cause 
of preterm delivery. Prior encouraged abortions mainly increased preterm delivery 
risks after idiopathic preterm labour, preterm premature rupture of membranes 
and ante‐partum haemorrhage, but not preterm delivery after maternal 
hypertension. The strength of the correlation increased with decreasing gestational 
age at birth. 
 
c)  Cervical incompetence 
Cervical Incompetence is diagnosed clinically by recurrent painless 
cervical dilation and spontaneous mid trimester abortions in the absence of 
membrane rupture, bleeding or infection. . This can lead to protrusion of the 
membranes into the vagina followed by expulsion of the immature foetus.  This 
may repeat in future pregnancies if not treated. 
 
Some of the causes are previous traumatization of the cervix caused by 
 Dilatation and curettage 
 Conisation 
 Cauterisation 
 Amputation of cervix 
 
 According to Albrechten and colleagues (2008) there is a fourfold risk of 
pregnancy loss before 24weeks in patients who had undergone cervical 
conisation. 
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d) Uterine anomalies: 
e) Pregnancy complications 
 Multiple pregnancies ,Hydramnios 
 Preeclampsia 
 Antepartum hemorrhage 
 Second trimester bleeding not due to placental causes 
 
Interval between pregnancies 
Interval between pregnancies play a major role in preterm labour. Intervals 
shorter than 18 months and longer than 59 months has been considered as 
increased risk for preterm & small for gestational age infants (Conde - Agudelo 
2006) 
 
Preterm births was increased if the interval between childbirth and LMP of 
next pregnancy was less than 3 months. Bloom et al in 2001 found a threefold 
increase in risk if   previous birth was preterm compared to a previous term 
pregnancy. A previous occurrence of preterm birth before 34 weeks may increase 
the risk of recurrence. (Krymko et al 2004) 
 
Foetal Gender 
Male babies have an increased chance of preterm delivery compared to 
female babies.  
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PATHOGENESIS OF PRETERM LABOUR 
The normal labour involves three components namely cervical ripening, 
myometial and foetal membrane activation. Preterm labour can be physiological 
or pathological if it occurs prematurely or due to an abnormal stimulus 
respectively. Though etiology of preterm labour is multifactorial infection is 
implicated in initiation of preterm labour. 
 
Withdrawal of progesterone theory established in parturition in sheep is not 
clear in humans. Increased synthesis of prostaglandins initiate parturition. 
 
The intrauterine tissues synthesise prostanoids which play an important 
role in the commencement or maintenance of labour in a number of species. The 
amnion during labour produces more amount of PGE2 (Mitchell, 1986; Casey and 
MacDonald, 1986), which stimulates the physiological process leading to birth. 
Though the stimulus for preterm labour varies the final pathway involves the 
inflammatory mediators cytokines. 
 
Cervical Ripening 
This involves transformation of firm long cervix to soft distendable cervix. 
Cervix is predominantly made up of connective tissue namely fibroblasts and 
extracellular matrix. At end of pregnancy, there is increase in collagenase activity 
and hyaluronic acid production which decrease the collagen content and increase 
the water content of cervix.Sex steroids and prostaglandins are involved in 
initiation of parturition. 
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Activation of foetal membranes 
During pregnancy, the chorioamnionic membranes fuse with the decidua. 
Many biochemical reactions occur in term and preterm labour which cause the 
separation of the foetal membranes from the decidua which results in rupture of 
membranes. Fibronectins are present at the chorionic-decidual interface which are 
degraded and released into cervical and vaginal secretions immediately before 
term and preterm parturition. Beyond proteolytic degradation of the decidual and 
amniochorionic extracellular matrix by matrix-degrading enzymes, PROM is also 
associated with amnion epithelial apoptosis and localized inflammation. 
Enzymatic activity of matrix proteases are involved in the processof rupture of 
membranes and parturition with intact membranes. 
 
Contraction of myometrium 
In pregnancy uterine contractions are inhibited by progesterone, relaxin, 
and nitricoxide. At the end of pregnancy these substances reduce making the 
uterus respond to uterotonic agents. Increase in intracellular concentration of 
calcium is implicated in uterine contractions. Though uterine contractions play a 
vital role in preterm labour compared to cervical ripening or foetal membrane 
activation studies involving myometrial activity are limited. 
 
 Prostaglandins play an important role in   preterm labour. Csapo (1961) 
proposed that labour commenced when the balance between myometrial 
stimulants and relaxants is lost. Prostaglandin endoperoxide H synthase increases 
the rate first, committed step of prostaglandin synthesis from arachidonic acid 
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(Smith et al, 1991). Prostaglandin endoperoxide H synthase activity increases in 
the amnion at parturition.  According to    DeWitt (1991) and Smith et al (1991), 
the prostaglandin endoperoxide H synthase expression is affected by various 
substances like growth factors, vascular cells, cytokines, steroids and tumour 
promoters in fibroblasts, and monocyte- and macrophage-like cells 
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Role of Cytokines in Preterm labour 
Cytokines such as interleukin 1,2, 6 and 8 and tumour necrosis factor are 
implicated in preterm labour. Infection is associated with by a host-inflammatory 
response, which causes accumulation of inflammatory cells in the chorioamnionic 
membranes and thereby increasing the expression of cytokines .This inflammatory 
process can trigger the onset of preterm labour by myometrial contractions, 
PPROM and cervical ripening. This is supported by the fact that there is an 
increased cytokine levels (e.g. interleukin-6 [IL-6] and IL-8) in the amniotic fluid 
of patients with preterm labour. .Interleukin 1 and tumour necrosis factor cause 
rupture of foetal membranes. 
 
In Sweden a study conducted about the association between the intra-
amniotic microbial colonisation and the levels of IL-6 and IL-8, and their 
association with preterm birth revealed that microorganisms in the amniotic fluid 
were detected in 16% of women in preterm birth and 25% of women with 
PPROM. It was also found that a high ratio of cases with preterm labour (43%) 
and PPROM (57%) had raised IL-6 and or IL-8 levels in the amniotic fluid, 
indicating an inflammatory response.  
 
Hence a solid relation between inflammation, microbialisation and preterm 
birth was established. Level of cytokines in amniotic fluid predicted preterm birth. 
Interleukin-18 has also been found to play a major role in preterm labour. It 
is produced as a proform and is stimulated  by the enzymecaspase-1. This in turn 
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activates  intracellular signalling pathway through interface with the IL-18 
receptor causing pro-inflammatory molecules, like interferon-g, tumour necrosis 
factor-a (TNF-a) and IL-1.Hence IL-18 can  be considered  to play a vital  role in 
infection leading to  preterm birth. Levels of IL-18 seem to be raised in the 
cervical and amniotic fluid of women in preterm labour compared with those not 
in labour  at term. 
 
DIAGNOSIS OF PRETERM LABOUR 
Cunningham Gil and co-workers (2001) found that preterm labour is 
established when regular uterine contractions occur at least 4 in 20 minutes or 8 in 
60 minutes with progressive change in cervical score with effacement 80% or 
more and dilatation more than 1 cm occurs.Preterm labour can be diagnosed by 
various factors .Preterm labour can be diagnosed by clinical methods and by 
investigations. 
 
Threatened preterm labour is a condition in which uterine contractions 
occur in the absence of cervical changes. 
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PAPIERNIK SCORING SYSTEM 
Points Socioeconomic factors 
Previous 
Obstetric 
/Medical 
History 
Social 
Aspects of 
current 
Pregnancy 
 
1 
 
Two living children 
low socioeconomic 
status 
H/o 1 abortion 
/ less than 1 
year of last 
child birth 
Employed Unusual fatigue 
 
2 
Maternal age <20 or 
>40 years/single 
parent 
H/o 2 abortions 
Smoker 10 
Cigarettes/ 
day/ moderate 
work 
Gain <5g by 32 
weeks 
 
 
3 
Very low 
socioeconomic 
status Ht< 150cm 
wt<45 kg 
H/o 3 abortion 
Heavy work / 
long distance 
traveling 
Breech 32 weeks/ 
weight loss /head 
engaged at 
32 weeks / febrile 
illness 
 
 
4 
Maternal age <18 
year Pyelonephritis  
Bleeding after 12 
weeks / short 
cervix open 
internal OS 
uterine 
irritability 
 
 
5 
 
Uterine 
anomaly 
second 
trimester 
abortion /DES 
exposure/cone 
biopsy 
 Placenta Praevia Hydramnios 
 
 
6 
 
Preterm 
delivery 
,repeated 
second 
trimester 
abortion 
 
Twins/ 
abdominal 
surgical 
procedure 
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SYMPTOMS 
 Menstrual like cramps 
 Low dull back ache 
 Increase or change in vaginal discharge 
 Uterine contractions 10 minutes apart or closer 
 
CLINICAL ASSESSMENT 
Uterine contractions 
Uterine contractions is the main symptom of preterm labour. There should 
be regular uterine contractions of at least 4 in 20 minutes or 8 in 60 minute each 
lasting not less than 40 seconds. 
 
Uterine Activity Monitoring 
Although teaching a woman to self-monitor her uterine contractions is a 
simple inexpensive method, there are lot of subjective variations in it which 
makes it less reliable .The perception of the contractions in terms of frequency 
,intensity, duration may vary between the health care providers hence a 
tocodynamometer can be used to assess the contractions. One of an earlier case 
control study reported a decrease in the preterm delivery rates on using the 
ambulatory monitoring system.(Katz et al 1986). 
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Current opinion is that for most patients home uterine monitoring is no 
better than frequent nursing care and support. Only patients, who cannot 
recognize the presence of uterine contractions adequately like multi foetal 
gestation and over distended uterus may benefit from home monitoring. 
 
These contractions are accompanied by progressive cervicalchanges. 
 
CERVICAL ASSESSMENT 
The clinical diagnosis of labour is dependent on the presence of uterine 
activity with cervical effacement and dilation. One of the main sign of term or 
preterm labour is cervical change. When patients come with the complaint of pain 
after confirming uterine contractions pelvic examination is done. The following 
features are assessed namely position, consistency, dilatation, effacement of the 
cervix. This digital examination is not precise as there are   inter- and intra-
operator errors. 
 
CERVICAL LENGTH 
Cervical length measurement by digital examination formed the gold 
standard for diagnosis of preterm labour. Women with shorter cervices 
experienced increased rates of preterm birth. 
 
The manual assessment of cervical length is subjective and has poor inter 
and intra observer variability. The cervix shortens and dilates at the level of 
internal cervical os. This process cannot be appreciated on a digital examination. 
Transvaginal ultrasound examination of cervical length is better than digital 
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examination in predicting preterm delivery. Hence cervical length measurement 
by ultrasound is used for prediction of labour. 
 
 The normal way of evaluating cervical length is by endo-vaginal 
ultrasound. Different measurements have been used to define short cervix. In 
patients with short cervical length, the “T” that is seen in ultrasound of cervix 
becomes “Y” and later on “U” as the amniotic sac descends. Though the 
conclusion of a short cervix does not mean incompetence and it is only a proposal, 
and neither can it identify, the pathological reasons for it. Before 1994, the studies 
done were surveyed by cerclage, making it harder to confirm. Later Jams et al; 
1994, reported a means cervical length at 24 weeks around 35mm with 
progressively shorter cervix had more changes of preterm delivery.  
 
Owen and co-workers concluded in 2003 that the value of cervical length 
to predict birth before 35 weeks is apparent only in high risk patients for preterm 
delivery .Studies by De Caralto et al 2005correlated the cervical length to preterm 
delivery. Hassan et al 2000 & 2001, found that when the cervical length was less 
than 25 mm, there was a high chance of preterm delivery with the normal mean 
length of cervix at 23 weeks of gestation being 35mm to 38 mm with the 10th and 
90th percentile being 25mm and 45mm respectively. 
 
A cervical length of 21mm at less than 20 weeks of gestation was shown 
by Cook et al (2000) to be associated with high risk preterm delivery. Owen et al 
(2001) showed at 3.3 time’s higher risk for preterm delivery if the cervical length 
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of 25 mm or less is seen at 16-19 weeks of pregnancy. An ultrasound screening 
every two weeks was also found to be significantly helpful (Andoers et al 2000). 
 
FUNNELING 
In women who are prone to deliver prematurely herniation of the foetal 
membranes occurs into the upper part of the endocervical canal.  
 
Although the length, width and relationship of funnel to cervical length 
have been studied, there are no uniform criteria to describe funnelling. The 
reporting of funnelling as present or absent on ultrasound is a significant 
conclusion to be cited as its found equivalent to dynamic cervical changes. Rust et 
al (2005) showed the risk of preterm labour, higher incidence of complication and 
cerclage placement in women with both cervical shortening and funnelling. 
 
Dynamic cervical changes 
The opening of the internal os and descent of the foetal membranes on 
fundal pressure during ultrasound was found to be significant risk factor for 
preterm labour (Gwzman et al, 1994). Passive or dynamic ultrasound finding of 
shortening of the cervix between 15 and 22 weeks is a significant predictor of 
additional cervical shortening (Gwzman et al, 1997). The myometrial activity in 
painless uterine contractions leads to dynamic changes and is an indication that 
that the cervix is opening during these contractions. 
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Cervical dilatation 
A study by Papiemik and his colleagues (1987) on cervical status before 37 
weeks, concluded that risk of preterm labour is increased by precocious cervical 
dilatation. According to Levino and associates, one in four women who had 
dilated cervices (2-3cm) between 26 and 30 weeks, had their delivery before 34 
weeks. Copper and associates (1995) have found that asymptomatic cervical 
dilation that occurs after mid pregnancy is significant preterm labour risk reason. 
Pereira and co-workers, (2007) identified cervical dilation as a predictor of a 
higher preterm delivery risk. 
 
CERVICAL INCOMPETENCE 
Premature cervical dilatation is associated with increased risk of preterm 
labour (Papiemik and colleagues 1987).In a study by Levino and associates one 
fourth of the women who cervices were dilated 2 to 3 cm between 26 and 30 
weeks delivered before 34 weeks .Asymptomatic dilatation of cervix after mid 
trimester is considered as a risk factor for preterm labour. In a study by Cook and 
Ellwood. Cervical status of nulliparous and parous women between 18 and 30 
weeks was followed up and both the groups gave birth to term. Copper and 
associates in 1995, Pereira and colleagues in 2007 have suggested cervical 
dilatation as an increased risk for preterm labour.  
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INVESTIGATIONS 
Foetal fibronectin 
 Foetal fibronectin is produced in 20 different types of molecular forms by 
different kinds of cells. These includes hepatocycles, fibroblasts, endothelial cells 
and foetal amnion.Foetal fibronectin is found in high concentration in both 
maternal blood and amniotic fluid. They are thought to play an initial role in 
intercellular adhesion during implantation and in maintaining placental attachment 
to the exterior decidue according to Lesson and colleagues (1996). 
 
 Foetal fibronectin is found in cervical secretions in term patients and 
normal patients with intact membranes. This denotes stromal remodelling of the 
cervix before labour. It is normally found in cervico vaginal secretions before 16-
18 weeks gestation before the fusion of the foetal membrane to thedecidual and 
then towards term prior to the onset of labour. It is usually not found between 22 
and 37 weeks of gestation.  
 
 Lockwood and co-workers in 1991 reported that fibronectin in 
cervicovaginal secretions can be considered as a marker for impending preterm 
labour. Swabs taken from posterior fornix or cervix is used for the detection of 
foetal fibronectin by ELISA method with FDG 6 monoclonal antibody. Value 
exceeding 50 mg/ml is considered as positive. Quantitative tests takes a longer 
time to develop, hence bedside tests have been developed. High false positive 
rates are there if sample is contaminated with amniotic fluid, semen, maternal 
blood, patients with encirclage. Goldberg and co- workers in 2000 reported 
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detection of fibronectin in the vaginal or cervical secretions as an important 
predictor of preterm labour. 
 
Leitich and co-workers performed a comprehensive meta-analysis on the 
efficacy of foetal fibronectin in identifying women at risk for preterm delivery. 
They noted that the test's usefulness was a result of its high specificity and was 
limited by the low sensitivity in identifying women who would go on to deliver 
prior to 34 weeks gestation. The sensitivity of the test decreased further in 
identifying women who would deliver prior to 37 weeks but increased when it 
was used serially. 
 
In order to maximize foetal fibronectin, its use should be restricted to 
women with intact membranes, cervical dilation less than 3 cm, and gestational 
age between 24 and 34 completed week’s gestation, and results should be 
available within 24 hours. False-positive foetal fibronectins may be obtained in 
women with recent intercourse or vaginal examinations or in the presence of 
bacterial vaginosis and vaginal bleeding. 
 
In general, the sensitivity of foetal fibronectin increases in symptomatic 
women, women with a cervical length of less than 2.5 mm, women with a history 
of prior preterm delivery, and women with bacterial vaginosis. The negative 
predictive value in women with preterm contractions ranges from 69% to 92% 
before 37 weeks gestation. Importantly, a negative foetal fibronectin has a 95% 
likelihood that delivery will not occur within 14 days of sampling.. 
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The Preterm Prediction Study of the National Institute of Child Health and 
Human Development analysed the sensitivity, specificity and predictive values of 
Bishop Score, fibronectin test and cervical length in predicting preterm labour in 
asymptomatic women (Iams et al, 2001) 
 
B-HUMAN CHORIONIC GONADOTROPHIN. 
STRUCTURE: 
 HCG  is a glycoprotein composed of 237 amino acids.Its  molecular  
weight is of 25.7 kDa.[7] 
 
                             
 
 It is a heterodimer, with an α (alpha) subunit which shares structural 
similiarity  luteinizing hormone (LH), follicle-stimulating hormone (FSH), 
thyroid-stimulating hormone (TSH) 
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β (beta) subunit is unique to hCG. 
 
 The α (alpha) subunit is composed of 92 amino acids.while the  β-subunit 
of hCG gonadotropin (beta-hCG) contains 145 amino acids.It is encoded by six 
highly homologous genes that are arranged in tandem and inverted pairs on 
chromosome 19q13.3  
   
SYNTHESIS: 
It is synthesized by syncytiotrophoblasts of human placenta. 
Its levels mirror the growth rate of the developing embryo. beta-hcg is 
present in high concentrations in the amniotic fluid and maternal serum during 
pregnancy, with a close correlation between their concentrations. The 
concentrations of beta-hcg in the maternal serum and amniotic fluid rises 
gradually and peaks between the eighth and 12th weeks of gestation and then 
declines and remains plateau from the 18th week of pregnancy onwards 
(Bernstein,etal,1998). During the process of labour, the choriodecidual interface is 
disrupted releasing B HCG  into the cervical secretions 
 
Diagnosis of preterm labour poses a major problem. Any test that can 
precisely diagnose preterm labour will be of much help. One of the latest modality 
in predicting preterm labour is B-HCG in cervical secretions..There is 
contradictory literature on the role of beta-hcg as a marker of preterm delivery. 
Some investigators believe that there is an association between the presence of 
beta-hcg in maternal serum and preterm delivery (Lieppman et al, 1993; Oneroglu 
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et al, 1997; Van et al, 1999; Goffinet et al, 2001; Benn et al, 1996; Liu et al, 
1999). However, there is also evidence suggesting that there is no relationship 
between them (Morssink et al, 1995, 1998). Alternatively the presence of beta-hcg 
in cervicovaginal fluid may be considered as a marker of preterm delivery, 
although the sensitivity, specificity, positive and negative predictive values vary 
between studies (Guvenal et al, 2001; Bernstein et al, 1998; Anai et al, 1997).  
 
BHCG levels can be qualitatively estimated by ELISA using sandwich 
technique with Monoclonal antibodies specific to the Beta subunit .Quantitative 
estimation is accomplished with the aid of immune chromatographic techniques. 
 
 The purpose of this study was to determine the correlation between 
concentration of beta-hcg in cervicovaginal secretions and preterm delivery. 
 
AMNIOCENTESIS TO DETECT INFECTION: 
There are several tests to analyse intra-amniotic infections. Tests done by 
Romero and his colleagues in 1993 in 120 women with intact membranes and 
preterm labour, were used to assess the value of amniotic fluid that had increased 
leukocyte counts, elevated interleukin -6 concentration or a positive Gram stain, 
and reduced glucose level. 
 
Those results with positive amniotic fluid culture were counted as infected.  
The experiments concluded that a negative Gram stain result was 99% to dismiss 
amniotic fluid bacteria. An increased value of interleukin-6 level, was 82% 
sensitive for finding out amniotic fluids that has bacteria. 
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There are other studies by Andrews and co-workers (1995) and Yoon and 
colleagues (1996) which have also proven that there exists a relation between the 
amniotic fluid inter leukin-6 levels (or leukocyte levels) and chorioamnio 
infections. Although these studies prove the relationship between the two, it is not 
confirmed that amniocentesis to identify infection is related with improved 
pregnancy results with or without rupture of membranes in women (Einstein and 
co-workers, 1986).It is determined that there is no indication to support routine 
amniocentesis to detect infection. 
 
OTHER  BIOCHEMICAL  MARKERS 
1. Salivary oestriol> 1.8/mi before 34 weeks has sensitivity of 68% and 
specificity of 76% for preterm labour before 35 weeks of 
gestation(Darne et al) 
2. Serum collagenase 
3. Tissue inhibitor of metalloproteinase (TIMP)/Matrix metalloproteinases 
4. Relaxin 
5. Corticotrophin Releasing Hormone 
 
These are of less practical value in prediction of preterm labour 
 
Mediators of Inflammation and Infection 
a) C — Reactive protein 
b) Granulocyte elastase 
c) Cytokines (IL-6, TNF) 
d) Amniotic Fluid Glucose Concentration 
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e) Zinc 
f) Lipocortin -l (Romeo R et al) 
g) Positive cultures 
h) Granulocyte colony stimulating factor 
 
These are not practically helpful in prediction of pre-term labour. 
 
MANAGEMENT OF PRETERM LABOUR 
The management of preterm labour includes 
 To prevent preterm onset of labour if possible 
 To arrest labour if not contraindicated 
 Appropriate management of labour 
 Neonatal care 
 
PREVENTION OF PRE TERM LABOUR 
Prevention is an important strategy in the management of a patient at high risk of 
preterm labour. The following guidelines are adopted: 
i)  Primary care 
Aimed to reduce incidence by reducing the high risk factors. 
ii)  Secondary care 
Screening for early detection and prophylactic treatment. 
iii)  Tertiary care 
Aimed to reduce the perinatal morbidity and mortality after the diagnosis. 
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Basic care 
Development of family support, education, supportive services from health 
care providers  
 Behavioural and life style modifications 
 Adequate nutrition. 
 Cessation of smoking (Burguet et al) 
 Avoidance of illicit drugs 
 
Bed rest, hydration and sedation 
Although bed rest and hydration are widely used as the first step of 
prevention, its practical benefit is questionable(Goldenberg et al).  
 
Kovacevich et al in his studies showed that bed rest of more than three 
days was associated with an increased occurrence of thrombocmbolic events in 
women with threatened pre-term labour. 
 
Some studies have reported the increased risk of development of 
pulmonary edema, when intravenous fluids are administered during tocolytic 
therapy. There is no substantial evidence of hydration therapy in causing 
pregnancy prolongation. Hydration therapy however has been rarely studied as a 
single therapy in prevention or treatment of pre-term labour. 
 
Cochrane systematic review showed no significant difference in the risk of 
pre-term labour in women who received hydration therapy. Comparative trials 
have been conducted between combination of sedation with hydration vs 
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intramuscular opiods in reducing the occurrence of preterm delivery and the 
results were found to be similar in both groups. 
 
Treatment of infections 
About 25 — 40 percent of preterm births are estimated to result from 
intrauterine infections (Cunningham et al 2010)  Morency and Buyold (2007) 
seemed to indicate that antibiotics given in the second trimester to females with a 
past of preterm labour would be effective in preventing reappearance of preterm 
labour. 
 
Most Randomized control trials show that intra vaginal clindamycin cream 
used to treat bacterial vaginosis did not reduce the rate of preterm birth. Carey et 
al (2000) used oral metronidazole to treat bacterial vaginosis but did not find a 
reduction in preterm birth. Methodical evaluation determined that screening and 
treatment of asymptomatic bacteruria and bacterial vaginosis may lessen the 
occurrence of preterm in low risk population 
 
Cervical encerclage 
Primary cerclages are placed prophylactically in women considered at high 
risk of preterm birth based on obstetric history. Secondary cerclages are placed 
when ultrasound findings are indicative of cervical insufficiency in high risk 
women. 
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Tertiary cerclages are done as an emergency process in the presence of 
positive clinical examination findings.The 1993 MRC/RCOG Multicenter 
Randomized experiment determined that clear benefit was seen only in patients 
with a history of three or more spontaneous births or preterm deliveries (Mac 
Naughton et al 1993) 
 
In 2001, CIPRACT Trial, Cervical Incompetence Prevention Randomised 
Cerclage Trial showed that patients with cervical insufficiency and cerclage 
placement had a lower incidence of preterm delivery prior to 34 weeks 
(ALTHUISIUS ET AL 2001) 
 
Rest Ct al 2000 concluded that cerclage failed to alter any perinatal 
outcome Daskalakis et al (2006) reported the benefits of emergency cerclage. In 
preterm labour Dor et al 1982 and Roman et al 2005 reported that elective 
cerclage had no benefit in twin gestation. Two randomized trials by Lazr et al and 
Rush et al showed no benefit of routine cerclage in women at moderate risk for 
preterm labour. 
 
EMERGENCY OR RESCUE CERCLAGE 
 There are certain studies that show that cervical incompetence and preterm 
labour together may lead to preterm delivery.Studies have analysed the 
importance of cerclage that is done after preterm labour initiates. If cervical 
incompetence is found with risk of preterm labour, emergency cerclage can be 
tried, although there is risks of pregnancy loss and infection (Harger, 1983). In an 
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experiment conducted by Althuisius and his co-workers, among 23 women with 
cervical incompetence before 27 weeks patients were subjected to bed rest with or 
without McDonald cerclage. The result was, that delivery delay was more in the 
group with cerclage than that of bed rest alone by 54 and 24 days respectively. 
 
 Another study was done  by Terkildsen and his colleagues in 2003 that 
included 116 women for whom second trimester emergency cerclage was 
attempted. Membranes that extended outside the external cervical os and cerclage 
before 22 weeks, were linked with substantial decreased occurrence of pregnancy 
continuance to 28 weeks or more. 
 
Progesterone 
Progesterone given as weekly intramuscular injections of 17 hydroxyl 
progesterone caproate from 16-20 weeks to 37 weeks showed significant decrease 
in preterm labour (Meis et al 2003) .It is not beneficial in twin pregnancies (Rouse 
et al 2007) (.Fonseca et al 2007) Micronized progesterone for asymptomatic 
women with very short cervix (Less than 15mm) appear to be effective for 
prevention of preterm delivery. 
 
As per AGOG (2008) progesterone is not recommended as a 
supplementary treatment to cervical cerclage for suspected cervical insufficiency 
or .as a preventive agent for asymptomatic women with a positive foetal 
fibronectin screen result or as a tocolytic agent. The role of progesterone in 
threatened preterm labour is uncertain (Cochrane Systematic Review 2006). 
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Cortico steroids 
The potential for antenatal administered corticosteroids to accelerate lung 
maturity was discovered by Liggens. In 1995 National Institute of Health 
consensus Development Panel recommended corticosteroids for foetal lung 
maturation in preterm infants, antenatal corticosteroids are recommended for all 
pregnant women between 25 and 34 weeks who are at risk of preterm delivery 
within 7 days. 
 
The initial reason for the usage of steroids in women with preterm delivery 
risk, was to avoid neonatal respiratory distress syndrome. After analysing a 
number of steroids administered pregnant women, it was revealed that there was 
another important benefit, which was the prevention of neonatal IVH. As there are 
such significant benefits of steroids administration, that overcome most of the 
theories that object such an approach about steroid usage, strong reasons must be 
justified for not using this treatment, especially in cases when preterm labour is 
going to occur before 30 weeks. 
 
Cochrane systematic analysis reported that antenatal corticosteroids reduce 
neonatal death respiratory distress syndrome, intra ventricular haemorrhage, 
necrotizing enter colitis in first 48 hours of life as well as reduction in the need for 
intensive care monitoring & respiratory support later 
 
For women with established preterm labour, a mix of betamethasone 
acetate (6mg) and betamethasone phosphate (6mg) must be administered 
intramuscularly, in consecutive two doses, with 24 hours interval, with no 
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contraindications for steroids. Some even prefer to use dexamethasone 4mg IM, 
for four doses every six hours.  
 
Roberts and Daiziel (2006) reviewed antenatal corticosteroids for 
accelerating foetal lung maturity Bruschettini and colleagues (2006) studied 
equivalent of 12 mg versus 6 mg beta methadone and reported that the lower dose 
had less severe effects on somatic growth without affecting cell proliferation Eli 
main and co-workers (2007) reported that betamethasone and dexamethasone 
were comparable in reducing the rates of major neonatal mortalities in preterm 
infants. 
 
According to Crowley, 1995, proposes that the effect of glucocorticoids, on 
foetal lung lasts not more than one week, through meta-analysis of random 
clinical trials. After this finding, the practice of administration of booster dose of 
betamethasone for every week for those who remained undelivered seven or more 
days after the early treatment, was adopted by many obstetricians.  
 
 Nevertheless, there are evidences that such a practice is linked with major 
fetal and neonatal side-effects, and it should be abandoned (Debbs et al, 1997; 
Banks et al, 1999; Vermillion et al 1999, Jobe et al, 1998; French et al, 1999) 
 
Though the maximum benefit of corticosteroid administration is between 
24 hours and 7 days after initiation of therapy they provide surgical advantage 
even when baby is delivered within 24 hours. 
  
41 
 
RESCUE CORTICOSTEROIDS 
 Rescue means giving a repetitive dose of corticosteroid when delivery is 
about to happen and more than 7 days have passed from the time of the first dose. 
It is said that rescue therapy should not be repetitively used and must be used 
mostly for clinical trials according to 2000 Consensus Development Conference. 
 
 In the trials conducted by Peltoniemi and his co-workers in 2007, that 
allotted 326 women to placebo or 12 mg betamethasone single dose rescue 
treatment. It concluded that the rescue dose increased the risk of respiratory 
distress syndrome. Later the American College of Obstetrics and Gynaecologists 
(2008) too recommends such method for trials. 
 
 Recently in a study of 437 women, less than 33 weeks who were 
administered rescue therapy or placebo, found that it reduced the rates of 
respiratory complications, and neonatal composite morbidity, with rescue 
corticosteroids according to Kurtzman and co-workers, 2009.  However there 
were nil differences in perinatal mortalities and other morbidities. There are also 
evidences that treated infants had better respiratory compliance (Mc Evoy and 
associates, 2009).  
 
PRINCIPLES OF MANAGEMENT IN WOMEN WITH PRETERM 
LABOUR 
1. Steroids to the mother to enhance lung maturity. 
2. Antenatal transfer of the mother to a centre equipped with NICU 
3. Tocolytic drugs 
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4. Antibiotics 
5. Careful intrapartum monitoring 
6. Vaginal delivery preferred unless cesarean birth is indicated.    
 
RECOMMENDED MANAGEMENT OF PRETERM LABOUR 
AGE : 34 weeks or more 
MANAGEMENT:  
 Proceed to delivery, usually be initiation of labour 
 Group B streptococcal prophylaxis is suggested 
 
AGE: 32 weeks to 33 completed weeks 
MANAGEMENT:  
 Expectant management unless fetal pulmonary  maturity is documented 
 Group B streptococcal prophylaxis is recommended 
 Corticosteroids-no consensus, but some experts recommend. 
 Antimicrobials to prolong latency if no contracindications. 
 
AGE: 24 weeks to 31 completed weeks 
MANAGEMENT 
 Expectant management 
 Group B streptococcal prophylaxis is recommended 
 Single course corticosteroids use is recommended. 
 Tocolytics – no census 
 Antimicrobials to prolong latency if no contraindications. 
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AGE: Before 24 weeks 
MANAGEMENT: 
 Patient counselling 
 Expectant management or induction of labour 
 Group B streptococcal prophylaxis is not recommended 
 Corticosteroids use is not recommended. 
 Antimicrobials-There are incomplete data on use in prolonging labour. 
 
TOCOLYTIC AGENTS 
Tocolysis is pharmacological suppression of uterine activity. 
Tocolytic drugs have been used in an attempt to inhibit preterm labour. 
They are effective in reducing the likelihood of delivery within 48 hours but do 
not reduce the overall risk of preterm labour. (ACOG 2007) 
 
Tocolytics may be required 
1.  To gain 48 hours to administer antenatal steroids for increasing 
pulmonary maturity 
2.  To permit in utero transfer of the patient to a tertiary care centre for 
Multi disciplinary management 
3.  Prepare for neonatal care 
4.  Preparing the patient for an operative delivery 
 
Variety of drugs which act on uterine smooth muscle to interrupt 
contractions are available these include magnesium sulphate, calcium channel 
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blockers, oxytocin antagonists, Non-steroidal anti-inflammatory drugs (NSAIDS) 
and beta mimetic agonists. 
 
As per ACOG 2003, choice of tocolytic agent is individualized and is 
usually based on the maternal condition. 
Absolute Contraindications to tocolytic therapy 
 Severe preeclampsia  
 Severe abruption 
 Severe bleeding, any cause  
 Frank chorioamnionitis  
 Foetal death  
 Foetal anomaly incompatible with life  
 Severe foetal growth restriction  
 Mature lung studies  
 Maternal cardiac arrhythmias 
 
Relative Contraindications to Tocolytic Therapy  
 Mild chronic hypertension  
 Mild abruption 
 Stable previa 
 Maternal cardiac disease  
 Hyperthyroidism  
 Uncontrolled diabetes mellitus  
 Foetal distress  
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 Foetal anomaly  
 Mild intrauterine growth restriction  
 Cervix greater than 4 cm dilated 
 
 SYMPATHOMIMETICS 
Cartis et al noted that small dose of epinephrine inhibited uterine 
hyperactivity .Efforts to produce an epinephrine like compound which lacked the 
cardiovascular stimulant effect culminated in the synthesis of beta agonists. 
 
They react with β adrenergic receptors to reduce intracellular ionized 
calcium levels and prevent activation of myometrial contractile proteins Beta 
mimetics can cause mild fall in diastolic blood pressure and isused cautiously in 
patients of ante partum hemorrhage. They also cause a slight increase of blood 
sugar in non-diabetic patient and hence can cause gestational diabetes when used 
for a longer duration alter thyroid function, elevated transaminases hypo calcemia, 
anti-diuresis and hypokalemia are the other metabolic effects of beta mimetics.. 
 
Some of the neonatal side effects of beta mimetics include increased risk of 
hypo calcemia, hypo glycemia and intraventricular haemorrhage.In recent time 
better drugs have replaced beta mimetics in regard to tocolytic function due to 
better profile of safety and less of adverse effects. 
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CLASSIFICATION 
1st Generation: Isoxsuprine, Orciprenaline, Isoprenaline 
2nd Generation: Ritodrine, Terbutaline, Fenoterol 
The most common used beta 2 agonist for tocolysis is ritodrine; then is 
terbutaline and salbutamol. 
 
RITODRINE 
Merkatz and colleages 1980 achieved a gestational age of 36 weeks in 
patients treated with ritodrine for threatened preterm labour.It is given as infusion 
at a dose of 50 ig/min and increased every 20 minutes until uterus is quiescent or 
side effects limit escalation of dose. 
 However the drugs have been implicated as a cause of increased 
capillary permeability, disturbance of cardiac rhythm and 
myocardial ischemia. 
 Side effects are palpitations, tremor, nausea, headache, chest pain 
dyspnea, pulmonary edema, hypokatemia, myocardial ischemia and 
arrhythmias. 
 Ritodrine was withdrawn voluntarily in 2003, according to Federal 
Register, United States owing to its adverse effects. 
 
TERBUTALINE 
Not used as much as ritodrine, but is effective in temporary suppression of 
uterine contractions when given parenterally. 
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 intravenous dose 5-10 1g/min ,increased every 10-15 mm to a maximum of 
80 g. 2.5 — 5 mg is the oral dose given every 4-6 hours and 250pg 
subcutaneously every 20-30 minutes given as 4-6 doses. 
 Terbutaline causes more hyperglycemia than ritodrine 
 
 Like ritodrine it can cause pulmonary edema (Angel and associates 1988) 
 
 Gunin and associates (1998) reported no significant prolongation or 
improved neonatal outcome with terbutaline is not approved by the FDA and 
therefore it’s not mentioned in any protocol for pre-term labour. Beta 2 agonists 
are no longer the first choice of drugs because of their side effects (RCOG 2002, 
Anotayanoth et al 2004) 
 
Contraindications of beta 2 agonist :symptomatic cardiac disease, 
conduction disturbance, hyperthyroidism, sickle cell disease, uncontrolled 
diabetes mellitus, chorioamionitis, severe preeclarnpsia, multifetal gestation and 
severe obstetrical bleeding. 
 
Prostaglandin Inhibitors 
Acetylsalicylate (Aspirin), Indomethacin naproxen fenamate, sulindac 
inhibit prostaglandin syntheses enzyme responsible for the transformation of free 
arachidonic acid to prostaglandins thereby decrease the myometrial gap junctions 
and influx of calcium. 
 
Indomethacin was first used as a tocolytic by Zuckerman and colleagues 
(1974) various trials compared indomethacin with other drugs like ritodrine; 
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Magnesium sulfate and found no difference in efficacy (Morales and coworkers 
(1989, 1193a). 
 
Indomethacin is administered orally or rectally. A dose of 50 to 100 mg at 
5 hours intervals, not to exceed 200 mg in 24 hours period. 
 
Adverse effects reported are oligohydramnios, pulmonary hypertension due 
to constriction of ductus arteriosus. Intra cellular hemorrhage, necrotizing 
enterocolitis have also been reported. 
 
Two randomized trials which compared the effect of indomethacin and 
placebo in delaying delivery showed no significant delay at 48 hours and 7 - 10 
days. 
 
MAGNESIUM SULPHATE 
Ionic magnesium in a sufficiently high concentration can alter myometrial 
contractility. Its role is presumably that of a calcium antagonist causing less 
intracellular calcium (Ca2+) to participate in actins myosin interaction during 
smooth muscle contraction.Elliott in his study found that Magnesium sulphate 
was effective tocolytic in 87% cases. 
 
Cox and associates in their study did not report any differences in the 
pregnancy outcome using magnesium sulphate.It affects neural transmission by 
modifying acetyl chloline release and sensitivity of motor end plate. 
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Drug concentration and effect 
 Contractility is inhibited at serum level of 5 - 8 mEq/L. 
 Deep tension reflexes are lost at 9 - 13 mEq/L. 
 Respiratory depression occurs at> 14 Meq/ dl 
 
 Loading dose of 4g IV given over 20 minutes followed by maintenance 
dose of 1-2 g / hour. 
 
Side effect is nausea, giddiness, flushing, hypocalonemia, respiratory 
depression, pulmonary edema and depressed motor respiratory activity in fetus. 
Contraindications of magnesium sulfate are myasthenia gravis, heart block, renal 
disease and recent myocardial infarction. 
 
Neuro protective effect of magnesium sulfate was evaluated in (BEAM 
study-Beneficial Effects of Antenatal Magnesium Sulfate)According to Gowther 
et al 2002, Cochrane systematic review, magnesium sulfate is an ineffective 
tocolytic..Wilkens et al 1989 reported the occurrence of significant side effect of 
magnesium sulphate while being used concurrently with beta mimetics for 
tocolysis. 
 
CALCIUM CHANNEL BLOCKERS 
These agents act by reducing the influx of calcium ions into the cell 
membrane during the inward calcium current of action potential. They block the 
voltage sensitive L type of calcium channels. They also decrease the tone of 
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smooth muscles by inhibition of intracellular calciwn from sarcoplasmic 
reticulum .Nifedipine is the most commonly used calcium channel blocker. 
 
King and colleagues 2003, Papatson’s 1997 concluded that calcium 
channel blockers especially Nifedipine are safer and more effective tocolytic 
agents than are beta agonists and have lower neonatal morbidity No significant 
change in utero placental flow has been reported .Mari et al (1989) 
 
TREATMENT  REGIMEN 
Optimal dose regimen of Nifedipine has not yet been defined. George et al 
1991, Read and WeIlby (1986), showed that initial dose of 30 mg followed by 20 
mg 8th hourly for 3 days had a success rate of 75% Andrenne et al gave a dosing 
regimen of 30 mg oral followed by a maintenance dose of 10 - 20mg orally every 
4 - 6 hours. 
 
Most trials advocated an initial loading dose of 30 mg of oral Nifedipine 
followed by 10 to 20 mg every 6 hours. Sublingual Nifedipine is no longer 
advocated due to risk of sudden hypotension. Onset of action is less than 20 
minutes with peak plasma concentration within 15 - 90 minutes. 
 
Having a half-life of 1.5 to 3 days. Elimination is mainly through kidneys 
(70%) and bowel 30%. Though the duration of action of a single dose can be as 
long as 6 hours, there is no apparent cumulative effect when administered every 6 
hours. 
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Side effects include facial flushing, nausea vomiting, headache, 
hypotension and tachycardia. No significant alteration in blood glucose and serum 
electrolytes was reported. 
 
OXYTOCIN ANTAGONIST (ATOSIBAN) 
Nona peptide oxytocin analog is a competitive antagonist of oxytocin 
induced contractions. 
 
Dosage 
 Recommended dose and administration schedule is a three step procedure. 
The initial bolus dose is 6.75 mg given over one minute, followed by an infusion 
of 18 mg/hour for three hours and 6 mg/hour for up to 45 hours. Treatment should 
not last longer than 48 hours and total dose given should not exceed 330 mg 
(RCOG, clinical Guidelines 2002) 
 
Side effects include nausea, vomiting, chest pain, and dyspnoea. 
 
In randomized clinical trials, artesian failed to improve relevant neonatal 
outcome and was linked with significant neonatal morbidity (Moutquin and 
coworkers, 2000 Romero and associates 2000) 
 
However, RCOG clinical guidelines 2002 suggested the first choice on 
administration of tocolytics to be oxytocin antagonist or Nifedipine. 
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NITRIC OXIDE DONORS (GLYCERYL TRINTRATE) 
It is a potent endogenous hormone having smooth muscle relaxant 
property. Main action affects vasculature, gut and uterus..Nitric oxide donors act 
by inhibiting CRH (Corticotrophin releasing hormone), a promoter of parturition. 
 
Dosage 10 mg Glycerol Tri nitrate patch placed over fundal region of 
maternal abdomen. Dose can be repeated with another 10 mg after one hour, if 
tocolysis is not achieved, to a maximum dose of 20 mg in 24 hours. Maternal 
hypotension is a common side effect. 
 
In randomized clinical trials, Nitroglycerine  administered orally, trans 
dermal or intravenously was not effective and was no superior to other tocolytics 
(Bistis 2004, Clavin 1996, Rees 1999, Buhimschi 2002. DuckittK et al (2002) 
reported that nitroglycerine did not improve neonatal outcome or delay delivery 
on comparison with placebo, no treatment or alternative tocolytics. 
 
POTASSIUM CHANNEL OPENERS 
Diazoxide is related to thiazide diuretics and its main use is in the 
treatment of malignant hypertension. Its mechanism of action is inhibition of 
smooth muscle contractility, thereby causing uterine quiescence. 
 
It is given in a dose of 5mg / kg, slow intravenous over 20-30 minutes. The 
drug is given after diluting with saline. Bolus dosage includes 50 -100 mg given 
every 5 minutes. 
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Side effects are tachycardia, hyperglycaemia, decreased blood pressure, 
and decreased utero placental flow secondary to hypotension in the mother. 
Hypoglycaemia and foetal distress are the side effects which occur secondary to 
maternal hypotension. 
 
FETAL AND NEONATAL RISKS 
Compromised foetal health is often the precipitating factor in threatened or 
actual preterm labour. Hence, intrauterine foetal death, intrauterine growth 
restriction, major congenital anomalies, unrecognized intrauterine infection, and 
complicated multiple pregnancy will all contribute tot he perinatal mortality and 
morbidity rates associated with preterm labour. 
 
RISKS OF PREMATURITY 
The gestational age at which threatened or actual preterm labour   presents, 
together with the birth weight, influences both the management and the outcome. 
In women presenting between 20 and 24 weeks' gestation, the management 
decision after discussion with the parents may be to allow delivery to occur 
because of the maternal risks from treatment and the likely poor prognosis for the 
baby if,  delivery can be postponed only for a few hours or days. 
 
Foetal intrapartum hypoxia and birth trauma associated with preterm 
labour involving the very low birth weightinfant, whether birth is by the vaginal 
or abdominal route, will contribute to the perinatal risk. The risks in the neonatal 
period are those of congenital malformation, intrauterine growth restriction, 
respiratory distress syndrome, necrotizing enterocolitis, intracranial haemorrhage, 
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convulsions, and septicemia. The foetal and neonatal risks associated with the 
medical management of preterm labour have not been accurately quantified, but 
they require consideration in the overall management. 
 
FETAL RISKS OF TOCOLYTIC AGENTS 
Beta-sympathomimetic tocolytic agents cross the placenta and may cause 
foetal tachycardia and occasionally other adverse foetal cardiac effects, which 
may be significant in an already compromised foetus. The maternal 
hyperglycaemia commonly associated with the use of these agents may result in 
neonatal hypoglycaemia. There is a suggestion that neonatal interventricular 
haemorrhage may be associated with the use of oral beta-sympathomimetic drugs, 
although the data are preliminary. There have been only a few small studies of 
possible long-term ill effects for the neonate, and currently it appears there is no 
difference in developmental outcome. 
 
Prostaglandin synthetase inhibitors (NSAIDs) cross from the mother to the 
foetus, potentially resulting in prolonged bleeding time, cardiopulmonary effects 
like premature closure or constriction of the ductus arteriosus and persistent foetal 
circulation, renal dysfunction, and reduced urinary output. Necrotizing 
enterocolitis and neonatal intra-ventricular haemorrhage have also been recorded 
in association with the use of these agents. Most studies have limited the use of 
prostaglandin synthetase inhibitors to short-term therapy (48–72 hours) before 32 
to 34 weeks gestation. Newer and possibly more specific prostaglandin synthetase 
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inhibitors such as sulindac, ketorolac, and the COX-2selective agents (e.g., 
nimesulide) are considered to have fewer foetal side effects. 
 
Magnesium sulfate  also readily crosses the placenta and may compromise 
foetal cardiac activity, with reduced baseline variability of the foetal heart rate 
demonstrated by cardiotocography being a common association, which in turn 
may lead to unnecessary intervention. The neonate may exhibit hypotonia and 
hypocalcaemia as a consequence of the hypomagnesaemia. The more 
controversial aspects of magnesium sulfate are related to its possible foetal 
neuroprotective role, as several observational studies indicated a reduction in 
cerebral palsy rate in very low birth weight infants in association with its use.  
 
Mitterdorf and associates,, have found in the ir small randomized 
controlled trial(MagNET trial) that there is a highly significant association 
between tocolytic magnesiumsulfate exposure and total neonatal mortality rates 
and worse out comes in relation to interventricular haemorrhage, periventricular 
leukomalacia, and cerebral palsy. 
 
Crowther and associates (2003) presented the much larger ACTO MgSO4 
trial and did not observe an increase in perinatal or neonatal mortality rate. A no 
significant reduction of adverse neurologic sequelae was reported.  
 
Calcium-channel blockers  have not been adequately evaluated with regard 
to foetal or neonatal effects, and the Cochrane reviewers recommended the 
assessment of different dose and formulations on maternal and neonatal outcomes. 
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Some animal studies have demonstrated profound metabolic alterations in the 
foetus, but these changes have not been confirmed in the foetuses of pregnant 
women. 
 
Newer tocolytic agents such as nitric oxide donors and oxytocin receptor 
antagonists have not been sufficiently assessed. The maternal administration of 
thyrotropin-releasing hormone in association with corticosteroids was thought, 
from preliminary studies, to enhance the development of foetal lung maturity. The 
ACTOBAT Study demonstrated results to the contrary and hence, its use is 
discouraged. 
 
Maternal corticosteroid administration to enhance foetal lung maturity is 
beneficial for the preterm neonate but may carry a number of risks, including 
infection, although the latest available data do not confirm this potential 
complication. These potential risks must be balanced against the proven beneficial 
effect on neonatal pulmonary function and the possible reduction in 
interventricularhaemorrhage and necrotizing enterocolitis.  
 
The Dutch trial which studied the effects of maternal prenatal 
corticosteroid administration, suggesteda long-term increase in the incidence of 
pharyngeal and ear infections in infants of treated mothers but reported no clear 
evidence of significant foetal or neonatal infection in preterm labour associated 
with intact membranes. The former practice of repeated maternal corticosteroid 
administration encouraged by the NIH Consensus Statement (1994) for 
pregnancies at risk for preterm delivery between 24 and34 weeks' gestation is 
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questionable. Crowley and associates, in their studies, suggested that there was 
little evidence of adverse long-term outcomes with repeated maternal 
corticosteroid administration.  
 
Walfisch and colleagues reviewed 280 articles on this topic and concluded 
that there are no well-designed randomized controlled trials (RCTs) in humans 
that support the advantages of multiple courses over a single course of antenatal 
corticosteroids. 
 
They also commented that an increasing body of evidence raises the 
concern of adverse consequences from the use of repeated courses. This 
conclusion is consistent with the current Cochrane systematic review of three 
trials. However, fewer infants required surfactant and there were fewer cases of 
severe respiratory distress syndrome (RDS) 
 
  
Aims & Objectives 
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AIM OF THE STUDY 
 
 TO MEASURE BETA HUMAN CHORIONICGONADOTROPHIN 
LEVELS IN CERVICOVAGINAL SECRETIONS IN WOMEN 
PRESENTING WITH  SYMPTOMS OF PRETERM LABOUR AND 
EVALUATE IT AS A PREDICTOR OF PRETERM DELIVERY. 
 
PRIMARY OBJECTIVE 
 TO DETERMINE THE RELATIONSHIP BETWEEN PRETERM 
DELIVERY AND CERVICOVAGINAL BETA HCG LEVELS. 
 
SECONDARY OBJECTIVE 
 TO EXPLORE THE ROLE OF NEW BIOCHEMICAL MARKERS IN 
PREDICTING SPONTANEOUS PRETERM BIRTH IN WOMEN WITH 
THREATENED PRETERM LABOUR. 
 
  
Materials & Methods 
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MATERIALS AND METHODS 
 
 This study was conducted in Institute of Social Obstetrics, Govt. Kasturba 
Gandhi Hospital for Women and Children and Institute of obstetrics,Government 
hospital for women and children Egmore under Madras Medical College, Chennai 
for the period of 10 months from December 2015 to August 2016. Institutional 
Ethics Committee approval was obtained from Madras Medical College for this 
study. 
 
Study Method 
 This was a prospective study which was carried out among pregnant 
women came with preterm pains from 28 weeks to 35 weeks 6 days(36 weeks) of 
gestational age. Sample size was calculated to 108 by using 7.72%72 prevalence of 
Preterm delivery with 5% precision. 
 
 Only those patients who could be followed up till term were included under 
the study after explaining in detail about the procedure and getting informed 
written consent. 
 
 The study design was prospective cohort. 
 
 Out of the 108 mothers chosen for the study based on inclusion and 
exclusion criteria  8 were excluded from study as 3 developed Gestational 
diabetes mellitus,1 developed pregnancy induced hypertension and 4 were lost for 
followup. 
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INCLUSION CRITERIA: 
 Singleton gestation (confirmed by early second trimester ultrasound) 
gestational age between 28-36 weeks(by LMP and confirmed by ultrasound) 
without any co morbid complications  with c/o preterm pains in this pregnancy. 
 
EXCLUSION CRITERIA: 
 Multiple gestation 
 Gestational diabetes mellitus 
 Pregnancy induced hypertension 
 Hydramnios 
 Cervical incompetence 
 Cardiovascular disease 
 Congenital fetal anamoly/malformation 
 Abruption placentae 
 Placenta previa 
 
METHODS 
 All chosen mothers will be subjected to detailed history followed by 
general and obstetric examination following which cervico vaginal secretions are 
collected for Beta HCG measurement. 
 
Sample collection: 
 For beta-hcg assay, cervicovaginal secretion samples will be obtained as 
follows .A cotton-tipped swab is placed first into the endocervical canal and 
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subsequently into the posterior fornix of vagina. The swab is  placed in a sterile  
tube containing 1ml of saline solution and shaken for one minute. The swab is 
disposed and samples were refrigerated and assayed within 72 hours.  
 
Laboratory Test  
 The beta-hcg levels of the samples were measured by an ELISA-based 
method using rapid EIA test kit Results will be reported in mIU/ml. 
 
 A cut off value of 25mIU/ml was considered to discriminate positive 
(>25mIU/ml) & negative(<25mIU/ml). 
 
 The patients were followed up till delivery and based on the gestational age 
at delivery were classified into preterm group and term group and the relationship 
of B HCG with gestational age at delivery was studied. 
 
  
Observation & Analysis 
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OBSERVATION AND ANALYSIS 
 
A.PROFILE OF CASES: 
 
1.AGE DISTRIBUTION. 
AGE GROUP Frequency Percent 
19-21 41 41.0 
22-24 45 45.0 
25-27 14 14.0 
Total 100 100.0 
 
 
 
 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
VAR00005 100 19.00 27.00 22.2300 1.98405 
Valid N 
(listwise) 100     
 
Among the mothers included in the study 41% were less than 20 years of age. 
  
41%
45%
14%
AGE DISTRIBUTION
19-21
22-24
25-27
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2. OBSTETRIC CODE. 
OBSTETRIC CODE NO OF CASES Percent 
G1 41 41.0 
G2 55 55.0 
G3 4 4.0 
Total 100 100.0 
 
 41% of the mothers included in the study were primis,rest were 
multigravida with 4% were third gravid and 55% were second gravidas. 
 
 
  
OBSTETRIC CODE
1
2
3
55%
41%
4%
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ABORTIONS 
PREVIOUS ABORTION NO OF CASES Percent 
No 93 93% 
yes 7 7% 
Total 10 100.0 
 
 
 
Only 7% of mothers had previous history of abortions.  
Abortion
No
yes
93%
7%
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3.GESTATIONAL AGE AT SAMPLE COLLECTION 
Gestational age in weeks No of cases Percent 
28 13 13.0 
29 1 1.0 
30 16 16.0 
31 1 1.0 
32 44 44.0 
34 13 13.0 
35 4 4.0 
36 8 8.0 
Total 100 100.0 
 
 B HCG was measured for  31% of mothers at < 32 weeks and 69% of 
mothers >32 weeks. 
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4.PREVIOUS HISTORY OF PRETERM 
Previous pre term Frequency Percent 
NO 77 77.0 
YES 23 23.0 
Total 100 100.0 
 
 Out of the mothers included in the study 23% had previous history of 
preterm and 77% presented with symptoms suggestive of preterm labour in 
present pregnancy. 
 
 
 
77%
23%
Previous pre term
NO
YES
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B.BHCG LEVELS IN CERVICOVAGINAL SECRETIONS 
BHCG 
Levels(in IU/L) Frequency Percent 
<25 90 90.0 
>25 10 10.0 
Total 100 100.0 
 
 Of the 100 cases taken for the study 10% had B hcg levels above the 
significant cut off chosen for the study. 
 
 
  
90%
10%
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<25
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C.DELIVERY OUTCOME(TERM Vs PRETERM). 
 Frequency Percent 
PRETERM 9 9.0 
TERM 91 91.0 
Total 100 100.0 
 
The incidence of preterm delivery was 9%. 
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91%
DELIVERY OUTCOME
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D.MODE OF DELIVERY 
Mode of delivery Frequency Percent 
LN 18 18.0 
LN EPI 53 53.0 
LSCS 29 29.0 
Total 100 100.0 
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E. RELATIONSHIP BETWEEN OUTCOME OF DELIVERY AND 
OTHER VARIABLES. 
 
1.MATERNAL AGE 
 pre_term N Mean Std. Deviation 
Std. Error 
Mean T value 
age 
Pre term 9 22.2222 1.98606 .66202 0.012 P=0.9904 
Term 91 22.2308 1.99487 .20912  
 
Non Significant   p>0.05 
 
 
 No significant association was found between maternal age and incidence 
of preterm delivery. 
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2. OBSTETRIC CODE 
 
RELATIONSHIP BETWEEN OBSTETRIC CODE AND PRETERM 
DELIVERY 
Outcome 
Obsteric_Code 
Total 
1 2 3 
Pre term 
Count 5 4 0 9 
% within obsteric_code 12.2% 7.3% 0.0% 9.0% 
Term 
Count 36 51 4 91 
% within obsteric_code 87.8% 92.7% 100.0% 91.0% 
Total 
Count 41 55 4 100 
% within obsteric_code 100.0% 100.0% 100.0% 100.0% 
 
 The percentage of preterm deliveries among primi and multigravidas did 
not have a statistically significant difference (Pearson Chi-Square 1.107  
p= 0.575). 
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3.PREVIOUS PRETERM DELIVERY 
 
outcome * previous_histroy Crosstabulation 
Outcome 
previous_histroy 
Total 
NO YES 
Pre term 
Count 5 4 9 
% within previous_histroy 6.5% 17.4% 9.0% 
Term 
Count 72 19 91 
% within previous_histroy 93.5% 82.6% 91.0% 
Total 
Count 77 23 100 
% within previous_histroy 100.0% 100.0% 100.0% 
 
 Though previous h/o preterm delivery was associated with increased 
incidence of preterm delivery, the association was not statistically 
significant(Pearson Chi-Square=2.568  p=0.109). 
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E.BHCG LEVELS AND PRETERM DELIVERY. 
 
Outcome * BCHG Crosstabulation 
Outcome BCHG Total 
<25 >25 
Pre term Count 2 7 9 
% within BCHG 2.2% 97% 9.0% 
Term Count 91 3 91 
% within BCHG 97.8% 3% 91.0% 
Total Count 93 7 100 
% within BCHG 100.0% 100.0% 100.0% 
 
 Out of 9 Preterm,  7 preterm  were >25. 
 
 Out of 9 preterm deliveries 7 mothers had BHCG > 25IU/L ,thus a 
significant association was found between increased B HCG levels in 
cervicovaginal secretions and preterm delivery( Pearson Chi-Square=76.105 
**P<0.001). 
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F.OUTCOME OF DELIVERY AND FETAL WEIGHT. 
 
outcome * BIRTH_WEIGHT Crosstabulation 
Outcome 
BIRTH_WEIGHT 
Total Upto 2.00 
KG 
2.01-
2.5 KG 
Above 
2.5 KG 
Pre term 
Count 6 3 0 9 
% within 
BIRTH_WEIGHT 100.0% 60.0% 0.0% 9.0% 
Term 
Count 0 2 89 91 
% within 
BIRTH_WEIGHT 0.0% 40.0% 100.0% 91.0% 
Total 
Count 6 5 89 100 
% within 
BIRTH_WEIGHT 100.0% 100.0% 100.0% 100.0% 
Pearson Chi-Square=85.348*P<0.001 
 Among the 9 preterm babies,6 had birth weight less than 2kg while 
remaining 3 weighed more than 2kg. 
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G.OUTCOME OF DELIVERY AND NICU ADMISSION. 
 
outcome * NICU Crosstabulation 
outcome 
NICU 
Total 
NO YES 
Pre term 
Count 0 9 9 
% within NICU 0.0% 64.3% 9.0% 
Term 
Count 86 5 91 
% within NICU 100.0% 35.7% 91.0% 
Total 
Count 86 14 100 
% within NICU 100.0% 100.0% 100.0% 
Pearson Chi-Square=60.754*P<0.001 
 All preterm babies required NICU admission,while among term delivery 
36% required NICU admissions for various reasons. 
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DISCUSSION 
 
 Preterm delivery is defined as birth occurring prior to 37 completed weeks 
of gestation..Incidence in India is 10% - 14% and developed countries 5% - 10%. 
 
 100 antenatal mothers were included in this study with the incidence of 
preterm delivery was 9%.Out of whom 7 mothers had cervicovaginal  BHCG 
levels >25 IU/L. 
 
 In the study conducted by soghra et al . A total of 83  pregnant women 
were studied of which Some  43%(n=36) subjects delivered at or before 37 weeks. 
Cervicovaginal beta hcg showed a range of 0 to 186mIu/ml with an optimal cut-
off value of 25, odds ratio for gestational age <37 was 3.016 (CI=1.12-8.06,95%). 
There was an association between preterm delivery (gestational age<37) and 
cervicovaginal beta-hcg titre in  28 weeks’ gestation.The study showed a 
sensitivity of 42% with a, specificity of 81%, positive and negative predictive 
values of the test was 63% and 64% respectively.  
 
 Garshasbi et.al studied βhCG levels of cervicovaginal secretions of patients 
who had a risk factor for preterm delivery, between 24 and 28 gestational weeks.  
Their study showed  the cut-off value of cervicovaginal βhCG was reported to be 
77.8 mIu/ml.  
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 According to this cut-off value the sensitivity, specificity and positive and 
negative predictive values for predicting delivery were 87%, 97%, 88.5% and 
98% respectively  These researches have concluded that cervicovaginal βhCG 
measurement in patients with preterm labor may be used as a predictive test.  
 
 In Ranjbar et al study, according of ROC curves, the cut-off of 
cervicovaginal βhCG secretions for predicting preterm labor and delivery and 
preterm labor & term delivery was 22.5 mIu/ml and the rate of sensitivity, 
specificity, positive and negative predictive value for cut-off were 97%, 76%, 
81% and 96%,respectively (Fig. 2); the cut-off value of cervicovaginal βhCG 
secretions for predicting preterm labor & preterm delivery and term delivery was 
18 mIu/ml and the rate of sensitivity, specificity, positive and negative predictive 
value for cut-off were 100%, 93%, 94% and 100%,respectively 
 
 In our study out of the total 100 participants presenting with preterm labour  
9% delivered at  <37 weeks..Out of these 7  had a BHCG value of  >25mIu/ml 
(p<0.001).chi square 76.105. 
 
 Among the total  10 mothers with BHCG > 25 IU/L ,7 delivered preterm 
rest had term deliveries. 
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 The sensitivity of the test was 77% with 96.7% specivicity indicating that 
mothers with BHCG <25 IU/L were less likely to have preterm deliveries. 
 
 The positive predictive value of our study was  70%  with a false positive 
of 3%.The negative predictive value was 97% . 
 
 Of  these 100 women 23% had  previous history of preterm delivery. 
Among these 17.4% delivered at <37 weeks.(p=0.109) 
  
Summary & Conclusion 
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SUMMARY AND CONCLUSION 
 
  To evaluate the association between elevated BHCG levels in 
cervicovaginal secretions and preterm delivery. 
 
 Our study group included 100 antenatal mothers without any co 
existing medical disorders who presented with either H/o preterm delivery 
in previous pregnancy or with symptoms suggestive of threatened preterm 
labour in present pregnancy at gestational age >28 weeks between  
December 2015-august 2016 at Government Kasturba Gandhi Hospital and 
Institute of Obstetrics and Gynecology, Egmore. 
 
 Cervicovaginal secretions were collected from all mothers by swab 
testing and levels of BHCG were estimated. They were assigned into two 
groups with BHCG <25IU/L and >25 IU/L respectively. All mothers were 
followed up outcome of delivery including gestational age and mode of 
delivery noted. 
 
The following observations were made. 
 In this study group age of mother and outcome of delivery was not 
significantly related. 
 
 Maternal obstetric code and delivery outcome was not statistically 
related. 
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 The study group with BHCG >25 IU/L 97% had preterm delivery 
while the remaining 3% delivered at term.( (p<0.001).chi square 76.105). 
 
 Our study had a sensitivity of 77% and specificity of 96.7% with an 
Odds ratio of 1.01. 
 
 Thus our study showed cervicovaginal BHCG levels to be a predictor 
preterm delivery. 
 
 
Bibliography 
  
BIBLIOGRAPHY 
 
1. Amini et al: Births to Teenagers: Trends and Obstetric Outcomes. 
Obstetrics & Gynecology: May 1996 
2. Astolfi P1, Zonta LA; PaediatrPerinatEpidemiol. 2002 Jan; 16(1):67-72. 
Delayed maternity and risk at delivery. 
3. Braner D, Kattwinkel J, Denson S, et al. American Heart Association, 
American Academy of Pediatrics. Textbook of Neonatal Resuscitation [M]. 
4th ed 
4. Burguet A, Kaminski M, Abraham Lerat L et al. Epipage Study group. 
The complex relationship between smoking in pregnancy and very preterm 
delivery. Results of the Epipage study Br J ObstetGynaecol 2004; 111: 
258-265. 
5. Berns S: Understanding Prematurity. Presentation at the 26th Annual 
International Neonatal Conference. Miami, FC, 2002. 
6. Bloom SL, Yost NP, McIntire DD, Leveno KJ; Recurrence of preterm 
birth in singleton and twin pregnancies. ObstetGynecol 2001; 98:379. 
7. Cnattingius S., Kyrklund-Blomberg: NB Preterm birth and maternal 
smoking: risk related to gestational age and onset of delivery. Am J 
ObstetGynecol 1998; 179 (4); 1051-5 
8. Crowther CA, Hiller JE, Doyle LW. Magnesium sulfate for preventing 
preterm birth in threatened preterm labour. Cochrane Database Syst Rev 
2002: Issue 4: CD 1001060. 
9. Cunnigham GH, Gant NF, Leveno KJ. Preterm birth in: Williams 
Obstetrics. 215t ed. Mc Graw Hill. USA. 2001; 27: 689-728. 
10. Daskalakis G, Papapanagiotou A, Mesogitis S. Bacterial vaginosis and 
Group B streptococcal infection and preterm delivery in low risk 
population. Fetal DiagnTher 2006; 2 1(2):172-6. 
11. Dolan and colleagues(2007). 
12. Duckitt K, Thorntons. Nitric Oxide donors for the treatment of preterm 
labour. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art 
No. CD002860. 
13. Darne J. et al., increased salivary oestriol to progesterone ratio before 
preterm delivery: Possible predictions for preterm labour Br. Med. J 1987: 
294-270-272. 
14. Da Fonseca EB, Bittar RE, Carvaiho MHB, et al: Prophylactic 
administration of progesterone by vaginal suppository to reduce the 
incidence of spontaneous preterm birth in women at increased risk. A 
Randomised placebo-controlled double blinded study. Am J 
ObstetGynecoll 188: 419, 2003. 
15. J.Espinoza, R.Romero,L.FGoncalves, J.P.Kusanovic and J.K.Nien: 
Assessment of Risk for Preterm Birth in Asymtomatic Patients and Those 
with Preterm Labour, :Textbook of Perinatal Medicine, Second edition. 
16. Elizur SE, Yinon Y, Seidman DS, Schiff E, Sivan E  Insulin-like growth 
factor binding protein-1 detection in preterm labor: evaluation of a bedside 
test. Am J Perinatol  2005;22(6):305-9. 
17. François Goffinet;Primary predictors of preterm laborMarch 2005 
Volume 112, Issue Supplement s1 Pages 1–121 
18. Goldenberg R and Rouse D: Prevention of premature birth. N Eilgl J ked 
1998; 339: 3l320. Gonik B, Greasy R.K.Pretem labour. Its diagnosis and 
management Am. J. Obs Gyn. 1986; 154: 3-8. 
19. Gravett MG, Hummel D, Eshenbach DA. Et al., Preterm labour associated 
with subclinical amniotic fliud infection and with bacterial vaginosis. 
20. Honest H, Bachmann LM, Gupta 1K, Kleijnen J, Khan KS. Accuracy of 
cervicovaginal fibronectin test in predicting results of spontaneous preterm 
birth: systematic review BMJ 2002; 325:301. 
21. Hickey, C.A., Cliver, S.P., McNeal, S.F. et al. (1997) Low pre gravid body 
mass index as a risk factor for preterm birth: variation by ethnic 
group. Obstet. Gynecol., 89, 206–212. 
22. Kaas EH. Pregnancy, pyelonephritis and prematurity. ClinObstet Gynecol. 
1970; 13(2):239-254.  
23. Kwek K, Khi C, Ting HS, Yeo GS. Evaluation of a bedside test for 
phosphorylated insulin-like growth factor binding protein-1 in preterm 
labour. Ann Acad Med Singapore  2004;33(6):780-3. 
24. Kistka et Al. Stamilio DM, Gross GA, Shanks A, DeFranco E, Chang 
JJ: Discussion: 'racial disparity in preterm birth' by Comment on Am J 
Obstet Gynecol. 
25. Krymko H, Bashiri A, Smolin A, Sheiner E, Bar-David J, Shoham-
Vardi I, et al. Risk factors for recurrent preterm delivery. Eur J 
ObstetGynecolReprod Biol. 2004;113:160–63 
26. Jeffcoat MK, Guers NC, Reddy MS, et al. Periodontal infection and 
preterm birth: results of a prospective study. Jam Dent Assoc. 2001; 
132:875-880, 51. 
27. Jean-Marie Moutquin: Socio-economic and psychosocial factors in the 
management and prevention of preterm labor: Volume 110, Issue 
Supplements 20, pages 56–60, April 2003. 
28. Lackman F, Capewell V, Richardson B,et al.. 2001. Journal ... The risks 
of   spontaneous preterm delivery and perinatal mortality in relation to size 
at birth according to fetal versus neonatal growth standards. Am J Obstet 
Gynecol. 2001Apr ;184(5): 
29. Lazar P., Guegen 5, Dreyfi.is J. et al. Multicentered controlled trial of 
cervical cerclage in women at moderate risk of preterm delivery, Br, J. 
Obstet. Gynecol.1984; 91:731. 
30. Lao TT1, Ho LF, Hum Reprod. 1997 Oct; 12(10):2303-5.The obstetric 
implications of teenage pregnancy. 
31. Lembet A, Eroglu D, Ergin T, Kuscu E, ZeynelogluH,Batioglu S, et al. 
New rapid bed-side test to predict  preterm delivery: phosphorylated 
insulin-like growth  factor binding protein-1 in cervical secretions. 
ActaObstetGynecolScand 2002;81(8):706-12. 
32. Lock wood C.J. et al., Fetal fibronection in cervical and vaginal 
secretion as a predictor of preterm delivery. EngI J. Ned. 1991: 325: 
669-674 
33. Leitich H, Kaider A: Fetal fibronectin—how useful is it in the prediction 
of preterm birth? Br J ObstetGynaecol2003; 110(suppl 20):66-70. 
34. Lumley J.M, Lieberman E. Ryan K.J. et al., Inter pregnancy interval and 
risk of preterm labour. Am. J. of epidemiology 1993: 122; 304-309. 
35. Mary L. Hediger: Young maternal age and preterm labor: PhD From the 
Department of Obstetrics and Gynecology, University of Medicine and 
Dentistry of New Jersey-SOM, Stratford, NJ, USA,1997 
36. Meis PJ, Goldenberg RL, Mercer BM, et al. The preterm prediction study: 
Risk factors for indicated preterm births. Am J ObstetGynecol 178:562, 
1998. 
37. Meis PJ, Michielutte R, Peters TJ, etal: Factors associated with preterm 
birth in Cardiff, Wales. Univariable and multi-variable analysis. Am J 
ObstetGynecol 173:590, 1995b. 
38. Meis PJ. National Institute of Child Heealth and Human Development 
Maternal Fetal Medicine Units Network. 17 alpha — hydroxyl 
progesterone acetate to prevent recurrent preterm biorth. Am J 
ObstetGynecol 2002; 187; 
39. Meis PJ, Klebanoff M, Thom E etal. National Institute of Child Health 
and Human Development Maternal Fetal Medicine units network. 
Prevention of recurrent preterm delivery by alpha — bydroxy progesterone 
caproate. N Engi J med 2003; 348; 2379-23 85. 
40.  Mills JL, Harlap S, Harley EE. Should coitus late in pregnancy be 
discouraged? Lancet 1981;2:136–8 
41. McIntire DD, Leveno KJ: 2008; Obstetrics and Gynecology; Jan; 111 (1); 
35-41: Objective: To analyse neonatal mortality and morbidity in late 
preterm. 
42. NeelamPotdar, OsricNavti and Justin C.Konje, 2009: Best Practices in 
Labour and Delivery: Antepartum haemorrhage ,  
pg 141  
43. Owen J, lams JD, Hauth JC: Vaginal Sonography and cervical 
incompetence. Am J ObstetGynecol 188: 586, 2003? 
44. Phillip R.Bennet, 2011, pg 131 Fetal and Neonatal Physiology: Expert 
Consult (2-Volume Set), Volume 2  By Richard A. Polin, William W. Fox, 
Steven H. Abman 
45. Papiernik E and Kaminski M. Multifactorial study of the risk of 
prematurity at 32 weeks of gestation I. A study of the frequency of 30 
predictive characteristics. J. Perinat. Med. 1974; 2: 30–36.  
46. Papiemik E. et al., precocious cervical ripening and preterm labour. J Obst 
and Gyn. 1987; 162: 1150-1153. 
47. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. The 
relationship between asymptomatic bacteriuria and prematurity/low birth 
weight (LBW) 
48. Roberts D, Dalziel SR. Antenatal coilicosteroids for accelerating fetal lung 
maturation for women at risk of preterm birth. Cochrane Database of 
Systematic Reviews 2006, Issue 23. Art. No. CD004454 
49. Robertson J.G., Livingstone J.R.B., Isdale M.H., The management and 
complications of asymptomatic bacteruria in pregnancy. Br. J. Obstet. 
Gynaecol. 1968:78:59. 
50. Rush R.W, Keirse M.N. M.C. et al, Contribution of preterm delivery to 
perinatal mortality Br. Med. J. 1976: 965-968. 
51. J ReprodImmunolPreterm labour: an intrauterine inflammatory response 
syndrome? 1997; 36:93. Arias F, Rodriguez L, Rayne SC, et al. Maternal 
placental vasculopathy and infection: 
52. Strigini FA, Lencioni G, De Luca G, eta. Uterine artery velocimetry and 
spontaneous preterm delivery. ObstetGynecol 1995; 85: 374-7. 52.  
53. Spong CY. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):405-15. Prediction and 
prevention of recurrent spontaneous preterm birth. 
54. Thomsen AC, Morup L, Brogaard Hansen K. Antibiotic elimination of 
group B streptococci in prevention of preterm labor. Lancet. 1987; 1:591.  
55. Human Reproduction (2004) 19 (3):  January 29, 2004 History of induced 
abortion as a risk factor for preterm birth in European countries: results of 
the EUROPOP survey. 
56. New rapid bed-side test to predict preterm delivery: phosphorylated 
insulin-like growth factor binding protein-1 in cervical secretions. 
Department of Obstetrics and Gynecology, Baskent University School of 
Medicine, Ankara, Turkey ActaObstetGynecolScand2002; 81: 706–712. C 
ActaObstetGynecolScand 81 2002. 
57. Ting HS, Chin PS, Yeo GS, Kwek K. Comparison of bedside test kits for 
prediction of preterm delivery: phosphorylated insulin-like growth factor 
binding  protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann  Acad 
Med Singapore 2007;36(6):399-402. 
58. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD; National Institute 
of Child Health and Human Development Neonatal Research Network: 
Apr 17, 2008.  
59. Vohr BR, Allen M. Extreme prematurity – the continuing dilemma. N Engl 
J  Med352:71,2005 
60. WHO 1995:  Preterm Birth:: Causes, Consequences, and Prevention, 
pg 134 
61. BMJ 1995; 311 doi: ttp://dx.doi.org/10.1136/bmj.311.7004.531 (Published 
26 August 1995)Cite this as: BMJ 1995;311:531 
62. Yost NP, Owen J, Berghella V, et al;Effect of coitus on recurrent preterm 
birth. Obstet Gynecol2006;107:793–7  
 
Annexures 
PROFORMA 
DATE: 
NAME:     AGE:                         LMP: 
 IP NO:                                                               EDD: 
D.O.A:                              D.O.D     
OBSTETRIC CODE: 
ADDRESS : 
 
PRESENTING  COMPLAINTS: 
MENSTRUAL  HISTORY :                            M/S: 
OBSTETRIC HISTORY: 
PAST HISTORY: 
GENERAL  EXAMINATION: 
HT:                        WT:                 TEMP:                        PR:                             BP: 
PALLOR:                                            PEDAL EDEMA: 
CVS:                                               RS: 
P/A:                                                                                 CONTRACTIONS: 
P/V: 
INVESTIGATIONS: 
HB:                        RBS:                           U/A:  
USG: 
 
B-HCG LEVELS IN VAGINAL SECRETION 
 
TREATMENT: 
 
STAY IN HOSPITAL: 
 
OUTCOME: 
 
RESULT: 
 
SNO NAME AGE IP NO G P L A LMP EDD PrPreterm
GA of 
preterm
GA at 
sample 
collection
BHCG
GA AT 
DELIVERY
MODE B.WT APGAR 1 APGAR 5 NICU
1 LAKSHMI 25 13014 2 1 1 2/7/2015 9/4/2016 YES 35 32 14.3 39 LN 2.8 7 9 NO
2 AMBIKA 24 13088 1 10/7/2015 12/4/2016 NO 32 16 38 LN EPI 3 8 8 NO
3 GRACE 22 13725 1 23/05/15 30/02/16 NO 36 12 38 LN 2.7 8 8 NO
4 SHEEBA 27 13645 2 1 1 29/6/15 6/4/2016 NO 32 11 38 LSCS 2.8 6 8 NO
5 LALITHA 23 13212 3 1 1 1 20/8/15 27/5/16 NO 32 18 37 LSCS 2.7 7 8 NO
6 LILY 25 13423 1 0 0 14/7/15 21/4/16 NO 32 26 34 LN 2 5 6 YES
7 JEBA 21 17625 2 0 0 1 24/8/15 31/5/16 NO 34 16 37 LN EPI 2.7 8 9 NO
8 RAMYA 24 13545 1 0 0 18/7/15 26/4/16 NO 35 22 37 LN 2.6 7 8 NO
9 FATIMA 22 13654 2 1 1 11/9/2015 18/6/16 YES 32 28 15 37 LN 2.5 7 8 YES
10 PRIYA 19 13767 1 0 0 22/7/15 29/4/16 NO 36 14 38 LSCS 3.2 7 8 NO
11 DEVI 20 13645 1 0 0 4/5/2015 11/2/2016 NO 36 11 38 LSCS 3.2 8 9 NO
12 ANNIE 22 13256 2 1 1 8/5/2015 15/2/16 YES 34 36 12 38 LN 2.6 8 9 NO
13 VEMBU 23 13897 2 1 1 19/9/15 26/6/16 NO 32 13 39 LN EPI 3 8 9 NO
14 KANIKA 21 13745 1 0 0 24/7/15 31/4/16 NO 32 28 33 LN 2 6 7 YES
15 VANI 25 13264 2 1 1 23/6/15 29/3/16 NO 34 24 38 LN EPI 2.8 8 9 NO
16 NITHYA 26 12546 2 1 1 12/7/2015 19/4/16 NO 32 15 39 LN 2.8 8 9 NO
17 RAJI 20 13612 1 30/6/15 7/4/2016 YES 32 36 14 38 LN EPI 2.9 8 9 NO
18 DIVIYA 22 13765 1 28/7/15 4/5/2016 NO 32 14.5 38 LN EPI 2.7 8 9 NO
19 PUSHPA 23 13243 2 1 1 10/5/2015 17/2/16 YES 34 36 15 39 LN EPI 2.9 8 9 NO
20 USHA 19 13906 1 17/7/15 24/4/16 NO 32 16 38 LN 2.9 8 9 NO
21 MARIYAM 20 13712 1 15/6/15 22/3/16 NO 32 15 39 LSCS 2.9 8 9 NO
22 ANITHA 24 13456 2 1 1 13/6/15 20/3/16 NO 30 16 38 LSCS 3 8 8 NO
23 AMBIKA 25 12434 2 1 1 19/7/15 26/4/16 NO 32 15 38 LSCS 2.9 8 9 NO
24 SATHYA 23 13762 2 1 1 21/5/15 28/2/16 NO 35 13.4 38 LN EPI 2.8 8 8 NO
25 VANITA 22 13154 2 1 1 13/6/15 20/3/16 NO 32 12 39 LN EPI 2.8 7 8 NO
26 MANJU 21 13651 1 3/6/2015 10/3/2016 NO 28 14 38 LN EPI 2.8 8 9 NO
27 RANI 21 13871 1 7/7/2015 14/4/16 NO 30 15 38 LN EPI 2.8 6 7 YES
28 KUMARI 26 13908 2 1 1 5/7/2015 12/4/2016 NO 34 16 38 LSCS 2.7 8 9 NO
29 NATHIYA 20 13710 1 8/5/2015 15/2/16 NO 36 14 37 LN EPI 2.8 8 8 NO
30 KOUSALYA 19 13004 1 11/7/2015 18/4/16 NO 30 15.6 38 LN EPI 3 8 9 NO
31 KALAI 19 13612 1 18/5/15 25/2/16 NO 32 12.5 38 LSCS 2.8 8 9 NO
32 BHARATHI 21 13817 2 1 1 4/6/2015 11/3/2016 NO 30 13.6 39 LN EPI 2.7 8 9 NO
33 THARANI 24 13945 2 1 1 12/6/2015 19/3/16 NO 32 12.5 38 LSCS 2.8 8 9 NO
34 SUKUMARI 20 13732 2 1 1 24/7/15 1/5/2016 NO 28 13.8 38 LSCS 2.8 5 6 YES
35 ANITHA 20 13767 1 22/8/15 29/5/16 NO 34 17 39 LN EPI 2.9 7 8 NO
36 SUJI 25 13634 2 1 1 28/7/15 4/4/2016 YES 34 32 29.7 34 LN 2.2 6 8 YES
37 VALLI 22 13624 1 14/9/15 21/6/16 NO 28 14.8 38 LN EPI 2.9 8 9 NO
38 RAMA 24 13898 2 1 1 11/10/2015 18/7/16 NO 28 16 39 LN EPI 2.8 8 9 NO
39 SHREYA 23 13909 2 1 1 15/11/15 22/8/16 NO 32 14 38 LSCS 2.8 9 9 NO
40 BLESSY 21 13709 2 1 25/10/15 2/8/2016 NO 30 15.2 38 LN EPI 2.9 8 8 NO
41 JAMILA 22 13203 2 1 1 15/10/15 22/8/16 NO 30 23 38 LN EPI 2.8 8 8 NO
42 MALIKA 22 13150 2 1 1 12/8/2015 19/5/16 NO 28 16.8 39 LN EPI 2.9 8 9 NO
43 SHANTHI 20 13265 2 1 1 10/10/2015 17/7/16 YES 32 30 28.5 32 LN 1.6 5 7 YES
MASTER CHART
44 JEYA 20 14512 3 1 1 1 24/10/15 31/7/16 NO 28 21 40 LN EPI 2.6 8 8 NO
45 MARY 19 12369 1 0 0 22/3/2015 29/12/16 NO 28 22 39 LSCS 2.6 7 8 NO
46 MALI 23 15125 1 0 0 24/4/15 31/1/16 NO 36 20 39 LN EPI 2.8 8 9 NO
47 SHELA 22 12487 2 1 1 12/5/2015 19/7/16 NO 32 14.8 39 LN EPI 2.7 8 9 NO
48 RAGA 21 11265 2 1 1 0 15/11/15 22/8/16 YES 32 28 12.8 40 LN EPI 2.7 8 8 NO
49 RAJI 22 12356 2 1 1 0 25/11/15 1/8/2016 NO 32 12.4 39 LSCS 2.7 7 8 NO
50 AJITHA 23 11478 2 1 1 0 2/10/2015 9/7/2016 YES 35 30 16.2 39 LN EPI 2.8 7 8 NO
51 JEYA 21 12698 2 1 4/6/2015 11/3/2016 NO 32 13.4 40 LN EPI 2.7 8 8 NO
52 ELAVARASI 25 13214 2 1 1 22/5/15 29/2/16 NO 30 12.4 37 LN EPI 2.6 8 9 NO
53 MARIYAMAL 19 12358 1 0 0 8/9/2015 15/6/16 NO 29 13.2 39 LN EPI 2.8 7 8 NO
54 JHANSI 20 11698 1 20/5/15 27/2/16 NO 34 14.6 39 LN EPI 2.8 8 8 NO
55 ALAMELU 26 13985 2 1 1 13/5/15 20/2/16 NO 32 15.2 39 LN EPI 3.2 8 9 NO
56 SHALINI 25 11956 2 1 1 14/11/15 21/8/16 NO 35 14.8 38 LN EPI 2.9 8 9 NO
57 RATHI 24 11265 2 1 1 15/8/15 22/5/16 YES 32 32 27.8 32 LN 1.8 7 7 YES
58 SIVARANJANI 21 11598 1 9/9/2015 16/6/16 NO 32 26.6 38 LSCS 2.9 8 8 NO
59 JANCY 22 12589 2 1 1 5/8/2015 12/5/2016 YES 34 28 28.8 32 LN 1.5 7 7 YES
60 KALAIVANI 19 11325 1 18/10/15 25/7/16 NO 30 15.4 37 LN 2.5 6 7 YES
61 NANDHINI 21 12698 1 21/9/15 28/6/16 NO 35 19 38 LSCS 3.8 7 8 NO
62 KANMANI 20 12698 2 1 11/7/2015 18/4/16 NO 34 15.6 39 LN EPI 2.9 7 8 NO
63 SAROJA 24 11569 2 1 1 8/6/2015 15/3/16 YES 36 32 14.7 38 LN EPI 3.2 8 9 NO
64 GAYATHRI 23 12365 2 1 1 12/6/2015 19/3/16 YES 34 32 16 39 LSCS 3.4 8 9 NO
65 KAVITHA 23 14865 2 1 1 15/10/15 22/7/16 NO 30 12.7 38 LSCS 2.8 8 9 NO
66 KANIKA 23 12314 2 1 1 19/10/15 26/7/16 NO 32 13.7 38 LSCS 2.8 8 9 NO
67 CLARA 26 11856 2 1 1 4/11/2015 11/8/2016 YES 32 34 18 39 lscs 2.9 8 8 NO
68 SHEELA 21 15369 1 18/11/15 25/8/16 NO 32 16 40 LN EPI 2.8 9 9 NO
69 TARA 20 14236 1 20/11/15 27/8/16 NO 30 15.7 38 LSCS 3.2 8 8 NO
70 PUSHPA 24 12657 1 22/11/15 29/8/16 NO 30 13.5 39 LN EPI 2.8 8 9 NO
71 TAMIL 23 12158 2 1 1 8/6/2015 15/3/16 NO 32 15.6 39 LN EPI 2.8 8 9 NO
72 SOBANA 21 13698 2 1 1 3/7/2015 10/4/2016 YES 30 32 26 38 LN 2.8 8 8 NO
73 KAVYA 23 12489 2 1 1     20/5/15 27/2/16 YES 32 31 12.9 39 LN EPI 2.9 9 9 NO
74 KIRUTHIKA 24 12176 2 1 1 24/6/15 31/3/16 YES 35 32 13.8 39 LSCS 2.9 8 8 NO
75 JAYANTHI 22 13125 1 13/4/15 20/1/16 NO 34 17.8 38 LSCS 2.8 8 8 NO
76 SOLAIYAMA 21 13265 1 16/8/15 23/5/16 NO 28 15 39 LN EPI 2.8 8 8 NO
77 SUGANTHI 22 13254 1 12/7/2015 19/4/16 NO 32 15.7 32 LN 1.8 7 8 YES
78 RATHIKA 21 12658 1 16/6/15 25/3/16 NO 30 16.7 32 LN EPI 2.2 8 9 YES
79 SANGEETHA 23 12478 1 2/6/2015 9/3/2016 NO 28 15 38 LN EPI 3 8 8 NO
80 SUGANYA 24 13432 3 1 0 1 9/6/2015 16/3/16 YES 34 32 18 39 LN EPI 2.8 8 8 NO
81 CHANDRA 21 14356 1 24/4/15 31/1/16 NO 34 12 39 LN EPI 2.9 9 9 NO
82 MANGAALAM 23 14347 1 13/8/15 20/5/16 NO 32 15 38 LSCS 3 6 7 YES
83 MANOGARI 24 12435 2 1 1 24/6/15 31/3/16 NO 32 14.8 39 LSCS 3.7 7 8 NO
84 SUBHA 25 13367 2 1 1 10/6/2015 17/3/16 NO 32 13.6 39 LN EPI 3.7 7 8 NO
85 JAYALAXMI 23 13278 2 1 1 8/5/2015 15/2/16 YES 28 34 14 38 LN EPI 2.8 7 8 NO
86 RAJALAXMI 21 14387 2 1 1 19/6/15 26/3/16 NO 32 13 39 LSCS 2.8 8 9 NO
87 NATHIYA 22 12345 1 20/7/15 27/4/16 NO 32 14 38 LN EPI 2.8 8 8 NO
88 DIVIYA 20 13248 1 21/7/15 28/4/16 NO 32 27 38 LN EPI 2.8 8 9 NO
89 KALAIVANI 21 13125 2 1 1 21/8/15 18/5/16 YES 32 14 38 LN EPI 2.8 8 8 NO
90 CHITHRA 23 14685 2 1 1 2/7/2015 9/4/2016 NO 28 15 39 LSCS 2.9 7 8 NO
91 KRISNAVENI 20 12487 1 15/8/15 22/5/16 NO 34 27 36 LN 2.3 7 8 YES
92 PRIYA 20 12698 2 1 1 4/5/2015 11/2/2016 YES 32 32 12 39 LN EPI 2.9 8 9 NO
93 ANUSHYA 21 12148 3 2 2 9/9/2015 16/6/16 NO 34 13 37 LN 2.6 8 8 NO
94 AMMU 21 12985 1 20/5/15 27/2/16 NO 32 11.8 38 LSCS 3.5 8 9 NO
95 ANUJA 20 13248 2 1 0 17/5/15 24/2/16 YES 34 32 21.7 39 LN EPI 2.8 9 9 NO
96 POORNA 23 12145 1 19/7/15 26/4/16 NO 30 13.5 38 LSCS 2.9 9 9 NO
97 SEETHA 27 12985 2 1 1 1/5/2015 8/2/2016 NO 32 15.6 38 LN EPI 3 7 8 NO
98 RABI 23 11698 2 1 1 5/5/2015 12/2/2016 NO 34 17.6 39 LN EPI 2.8 8 9 NO
99 ROSE 24 12678 2 1 1 22/4/15 29/1/16 NO 32 13.5 38 LN EPI 3.2 9 9 NO
100 ANNAPOORANI 23 13456 1 26/11/15 3/9/2016 YES 30 16 38 LN EPI 3 9 9 NO
 
  
 
  
 
  
 
  
 
  
 
  
 
